ATF 1 19 5 Type=GenePix arrayList V1.0 BlockCount=16 BlockType = 0 "Block1= 0 0 100 12 350 10 400" "Block2= 4500 0 100 12 350 10 400" "Block3= 9000 0 100 12 350 10 400" "Block4= 13500 0 100 12 350 10 400" "Block5= 0 4500 100 12 350 10 400" "Block6= 4500 4500 100 12 350 10 400" "Block7= 9000 4500 100 12 350 10 400" "Block8= 13500 4500 100 12 350 10 400" "Block9= 0 9000 100 12 350 10 400" "Block10= 4500 9000 100 12 350 10 400" "Block11= 9000 9000 100 12 350 10 400" "Block12= 13500 9000 100 12 350 10 400" "Block13= 0 13500 100 12 350 10 400" "Block14= 4500 13500 100 12 350 10 400" "Block15= 9000 13500 100 12 350 10 400" "Block16= 13500 13500 100 12 350 10 400" Block Row Column ID Name 1 1 1 L25899 Ribosomal protein L10 1 1 2 BC013590.1 eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa; EIF2B5 1 1 3 NM_002962.1 S100 calcium binding protein A5; S100A5 1 1 4 NM_000433.2 neutrophil cytosolic factor 2 (65kDa, chronic granulomatous disease, autosomal 2); NCF2 1 1 5 NM_005356.2 lymphocyte-specific protein tyrosine kinase; LCK 1 1 6 NM_001986.1 ets variant gene 4 (E1A enhancer binding protein, E1AF); ETV4 1 1 7 NM_001839.2 calponin 3, acidic; CNN3 1 1 8 NM_004833.1 absent in melanoma 2; AIM2 1 1 9 NM_145911.1 zinc finger protein 23 (KOX 16); ZNF23 1 1 10 BT020132.1 CD151 antigen; CD151 1 1 11 NM_002524.2 neuroblastoma RAS viral (v-ras) oncogene homolog; NRAS 1 1 12 K00558 Alpha tubulin_2 1 2 1 obsaracontrol#014 control oligonucleotide 1 2 2 NM_001987.3 ets variant gene 6 (TEL oncogene); ETV6 1 2 3 AJ132948.1 tripartite motif-containing 33; TRIM33 1 2 4 NM_002001.2 Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide; FCER1A 1 2 5 NM_012450.2 solute carrier family 13 (sodium/sulfate symporters), member 4; SLC13A4 1 2 6 BC005080.1 immediate early response 3; IER3 1 2 7 NM_003929.1 RAB7, member RAS oncogene family-like 1; RAB7L1 1 2 8 NM_000851.2 glutathione S-transferase M5; GSTM5 1 2 9 NM_003747.2 tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase; TNKS 1 2 10 S52508.1 zinc finger protein 125 (HZF-3); ZNF125 1 2 11 NM_000982.3 ribosomal protein L21; RPL21 1 2 12 BC021117.1 colony stimulating factor 1 (macrophage); CSF1 1 3 1 NM_000316.2 parathyroid hormone receptor 1; PTHR1 1 3 2 NM_001046.2 solute carrier family 12 (sodium/potassium/chloride transporters), member 2; SLC12A2 1 3 3 AB209992.1 desmoplakin; DSP 1 3 4 AY196488.1 WNT1 inducible signaling pathway protein 1; WISP1 1 3 5 AC092417.2 Homo sapiens chromosome 3 clone RP11-90M23, complete sequence;; 1 3 6 NM_007255.1 xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I); B4GALT7 1 3 7 NM_003495.2 histone 1, H4i; HIST1H4I 1 3 8 NM_004331.2 BCL2/adenovirus E1B 19kDa interacting protein 3-like; BNIP3L 1 3 9 AB020522.1 deleted in lung and esophageal cancer 1; DLEC1 1 3 10 NM_021025.2 T-cell leukemia, homeobox 3; TLX3 1 3 11 NM_000416.1 interferon gamma receptor 1; IFNGR1 1 3 12 NM_001738.1 carbonic anhydrase I; CA1 1 4 1 NM_015873.3 villin-like; VILL 1 4 2 NM_002084.3 glutathione peroxidase 3 (plasma); GPX3 1 4 3 NM_003537.3 histone 1, H3b; HIST1H3B 1 4 4 NM_000067.1 carbonic anhydrase II; CA2 1 4 5 NM_006010.2 arginine-rich, mutated in early stage tumors; ARMET 1 4 6 AB102802.1 interleukin 6 signal transducer (gp130, oncostatin M receptor); IL6ST 1 4 7 NM_006519.1 dynein, light chain, Tctex-type 1; DYNLT1 1 4 8 NM_007332.1 transient receptor potential cation channel, subfamily A, member 1; TRPA1 1 4 9 BC012884.1 CD47 antigen (Rh-related antigen, integrin-associated signal transducer); CD47 1 4 10 NM_016269.2 lymphoid enhancer-binding factor 1; LEF1 1 4 11 NM_001527.1 histone deacetylase 2; HDAC2 1 4 12 NM_004063.2 cadherin 17, LI cadherin (liver-intestine); CDH17 1 5 1 NM_005736.2 ARP1 actin-related protein 1 homolog A, centractin alpha (yeast); ACTR1A 1 5 2 NM_005639.1 synaptotagmin I; SYT1 1 5 3 NM_006291.2 tumor necrosis factor, alpha-induced protein 2; TNFAIP2 1 5 4 AE006464.1 Homo sapiens 16p13.3 sequence section 3 of 8;; 1 5 5 AL603965.10 Human DNA sequence from clone RP11-145E20 on chromosome 10 Contains a ARF GTPase-activating protein (MRIP2) pseudogene, the gene for a novel protein similar to annexin A8 (ANXA8) the 5' end of a novel gene similar to LOC195977 (FLJ32754), a novel pseudoge 1 5 6 NM_003806.1 harakiri, BCL2 interacting protein (contains only BH3 domain); HRK 1 5 7 NM_014226.1 renal tumor antigen; RAGE 1 5 8 BC010094.2 phosphatidylinositol glycan, class Q; PIGQ 1 5 9 AJ509182.1 Fas (TNF receptor superfamily, member 6); FAS 1 5 10 NM_000519.3 hemoglobin, delta; HBD 1 5 11 NM_003403.3 YY1 transcription factor; YY1 1 5 12 NM_006428.3 mitochondrial ribosomal protein L28; MRPL28 1 6 1 NM_004897.2 multiple inositol polyphosphate histidine phosphatase, 1; MINPP1 1 6 2 BC008080.2 splicing factor 1; SF1 1 6 3 NM_005249.3 forkhead box G1B; FOXG1B 1 6 4 NM_002528.4 nth endonuclease III-like 1 (E. coli); NTHL1 1 6 5 BC042943.2 USP6 N-terminal like; USP6NL 1 6 6 BC002664.2 multiple endocrine neoplasia I; MEN1 1 6 7 NM_021033.4 RAP2A, member of RAS oncogene family; RAP2A 1 6 8 NM_001089.1 ATP-binding cassette, sub-family A (ABC1), member 3; ABCA3 1 6 9 NM_021252.3 RAB18, member RAS oncogene family; RAB18 1 6 10 NM_014205.2 zinc finger, HIT type 2; ZNHIT2 1 6 11 X64624.1 POU domain, class 4, transcription factor 1; POU4F1 1 6 12 NM_003470.1 ubiquitin specific peptidase 7 (herpes virus-associated); USP7 1 7 1 BC063447.1 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1; CTDP1 1 7 2 CR620285.1 pregnancy specific beta-1-glycoprotein 11; PSG11 1 7 3 BC051357.1 zinc finger protein 278; ZNF278 1 7 4 BC037545.1 poly (ADP-ribose) polymerase family, member 1; PARP1 1 7 5 NM_000529.2 melanocortin 2 receptor (adrenocorticotropic hormone); MC2R 1 7 6 NM_001020.4 ribosomal protein S16; RPS16 1 7 7 NM_014303.2 pescadillo homolog 1, containing BRCT domain (zebrafish); PES1 1 7 8 NM_000396.2 cathepsin K (pycnodysostosis); CTSK 1 7 9 NM_000386.2 bleomycin hydrolase; BLMH 1 7 10 NM_003260.3 transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila); TLE2 1 7 11 NM_020530.3 oncostatin M; OSM 1 7 12 BC052584.1 mitogen-activated protein kinase-activated protein kinase 2; MAPKAPK2 1 8 1 NM_004618.3 topoisomerase (DNA) III alpha; TOP3A 1 8 2 NM_001828.4 Charcot-Leyden crystal protein; CLC 1 8 3 NM_000268.2 neurofibromin 2 (bilateral acoustic neuroma); NF2 1 8 4 NM_000491.3 complement component 1, q subcomponent, beta polypeptide; C1QB 1 8 5 NM_003620.2 protein phosphatase 1D magnesium-dependent, delta isoform; PPM1D 1 8 6 NM_001626.2 v-akt murine thymoma viral oncogene homolog 2; AKT2 1 8 7 AY551305.1 CHK2 checkpoint homolog (S. pombe); CHEK2 1 8 8 NM_000696.2 aldehyde dehydrogenase 9 family, member A1; ALDH9A1 1 8 9 NM_003258.1 thymidine kinase 1, soluble; TK1 1 8 10 NM_006297.1 X-ray repair complementing defective repair in Chinese hamster cells 1; XRCC1 1 8 11 NM_004175.3 small nuclear ribonucleoprotein D3 polypeptide 18kDa; SNRPD3 1 8 12 NM_007314.1 v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene); ABL2 1 9 1 NM_000662.4 N-acetyltransferase 1 (arylamine N-acetyltransferase); NAT1 1 9 2 NM_000057.1 Bloom syndrome; BLM 1 9 3 NM_005238.2 v-ets erythroblastosis virus E26 oncogene homolog 1 (avian); ETS1 1 9 4 AF083811.1 MAD1 mitotic arrest deficient-like 1 (yeast); MAD1L1 1 9 5 AK128645.1 syndecan binding protein (syntenin); SDCBP 1 9 6 BC000278.1 carbonic anhydrase XII; CA12 1 9 7 NM_022725.2 Fanconi anemia, complementation group F; FANCF 1 9 8 X83929.1 desmocollin 3; DSC3 1 9 9 BC091494.1 fibroblast growth factor receptor 1 (fms-related tyrosine kinase 2, Pfeiffer syndrome); FGFR1 1 9 10 J00071.1 actin, alpha, cardiac muscle; ACTC 1 9 11 NM_001010.2 ribosomal protein S6; RPS6 1 9 12 CR623041.1 melanoma antigen family A, 4; MAGEA4 1 10 1 M26880 ubiquitin_2 1 10 2 AK000895.1 chromosome 14 open reading frame 118; C14orf118 1 10 3 NM_024522.1 family with sequence similarity 77, member C; FAM77C 1 10 4 NM_024616.1 TPA-induced transmembrane protein; TTMP 1 10 5 NM_007257.4 paraneoplastic antigen MA2; PNMA2 1 10 6 NM_001049.2 somatostatin receptor 1; SSTR1 1 10 7 BT006816.1 microseminoprotein, beta-; MSMB 1 10 8 NM_000799.2 erythropoietin; EPO 1 10 9 NM_002755.2 mitogen-activated protein kinase kinase 1; MAP2K1 1 10 10 NM_000053.2 ATPase, Cu++ transporting, beta polypeptide; ATP7B 1 10 11 NM_030666.2 serpin peptidase inhibitor, clade B (ovalbumin), member 1; SERPINB1 1 10 12 X63432 beta-actin, replicated spot 2 1 1 K00558 Alpha tubulin_2 2 1 2 NM_001323.2 cystatin E/M; CST6 2 1 3 BC050642.2 enolase 1, (alpha); ENO1 2 1 4 NM_020981.2 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1; B3GALT1 2 1 5 BC071758.1 T cell receptor alpha locus; TRA@ 2 1 6 NM_004668.1 maltase-glucoamylase (alpha-glucosidase); MGAM 2 1 7 BC008058.2 protein kinase C, zeta; PRKCZ 2 1 8 NM_000122.1 excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing); ERCC3 2 1 9 NM_006818.3 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11; MLLT11 2 1 10 NM_004304.3 anaplastic lymphoma kinase (Ki-1); ALK 2 1 11 NM_005427.1 tumor protein p73; TP73 2 1 12 K00558 Alpha tubulin_2 2 2 1 NM_005997.1 vacuolar protein sorting 72 (yeast); VPS72 2 2 2 obsaracontrol#015 control oligonucleotide 2 2 3 NM_002440.2 mutS homolog 4 (E. coli); MSH4 2 2 4 NM_004622.2 translin; TSN 2 2 5 BC026062.2 fusion (involved in t(12;16) in malignant liposarcoma); FUS 2 2 6 NM_006143.1 G protein-coupled receptor 19; GPR19 2 2 7 NM_002870.2 RAB13, member RAS oncogene family; RAB13 2 2 8 NM_002643.2 phosphatidylinositol glycan, class F; PIGF 2 2 9 NM_006694.2 jumping translocation breakpoint; JTB 2 2 10 NM_005479.2 frequently rearranged in advanced T-cell lymphomas; FRAT1 2 2 11 NM_003820.2 tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator); TNFRSF14 2 2 12 NM_000090.2 collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant); COL3A1 2 3 1 NM_012219.2 muscle RAS oncogene homolog; MRAS 2 3 2 NM_004520.1 kinesin heavy chain member 2; KIF2 2 3 3 J03464.1 collagen, type I, alpha 2; COL1A2 2 3 4 NM_003798.1 catenin (cadherin-associated protein), alpha-like 1; CTNNAL1 2 3 5 NM_003298.3 nuclear receptor subfamily 2, group C, member 2; NR2C2 2 3 6 BC006837.1 RAD1 homolog (S. pombe); RAD1 2 3 7 NM_002835.2 protein tyrosine phosphatase, non-receptor type 12; PTPN12 2 3 8 BC011776.2 tropomyosin 2 (beta); TPM2 2 3 9 NM_003256.2 TIMP metallopeptidase inhibitor 4; TIMP4 2 3 10 NM_001737.2 complement component 9; C9 2 3 11 BC042531.1 ATP-binding cassette, sub-family B (MDR/TAP), member 4; ABCB4 2 3 12 NM_006914.3 RAR-related orphan receptor B; RORB 2 4 1 NM_004526.2 MCM2 minichromosome maintenance deficient 2, mitotin (S. cerevisiae); MCM2 2 4 2 NM_003633.1 ectodermal-neural cortex (with BTB-like domain); ENC1 2 4 3 CR610114.1 sorcin; SRI 2 4 4 NM_000380.2 xeroderma pigmentosum, complementation group A; XPA 2 4 5 NM_000373.1 uridine monophosphate synthetase (orotate phosphoribosyl transferase and orotidine-5'-decarboxylase); UMPS 2 4 6 X69878.1 fms-related tyrosine kinase 4; FLT4 2 4 7 BC025422.2 cut-like 1, CCAAT displacement protein (Drosophila); CUTL1 2 4 8 NM_003177.3 spleen tyrosine kinase; SYK 2 4 9 NM_003615.2 solute carrier family 4, sodium bicarbonate cotransporter, member 7; SLC4A7 2 4 10 BX537441.1 RAD17 homolog (S. pombe); RAD17 2 4 11 NM_014069.1 psoriasis susceptibility 1 candidate 2; PSORS1C2 2 4 12 NM_007018.4 centrosomal protein 1; CEP1 2 5 1 BC001506.2 CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344); CD59 2 5 2 NM_016551.1 transmembrane 7 superfamily member 3; TM7SF3 2 5 3 AL833875.1 mutL homolog 3 (E. coli); MLH3 2 5 4 NM_000502.2 eosinophil peroxidase; EPX 2 5 5 BC036655.1 suppression of tumorigenicity 5; ST5 2 5 6 NM_005086.3 sarcospan (Kras oncogene-associated gene); SSPN 2 5 7 NM_007176.1 chromosome 14 open reading frame 1; C14orf1 2 5 8 BC000729.2 A kinase (PRKA) anchor protein 1; AKAP1 2 5 9 BC052287.1 CD44 antigen (homing function and Indian blood group system); CD44 2 5 10 BT020138.1 CD63 antigen (melanoma 1 antigen); CD63 2 5 11 BC015024.1 alkB, alkylation repair homolog (E. coli); ALKBH 2 5 12 NM_001258.1 cyclin-dependent kinase 3; CDK3 2 6 1 NM_006500.2 melanoma cell adhesion molecule; MCAM 2 6 2 NM_002868.2 RAB5B, member RAS oncogene family; RAB5B 2 6 3 NM_004239.1 thyroid hormone receptor interactor 11; TRIP11 2 6 4 NM_001330.2 cardiotrophin 1; CTF1 2 6 5 BC001061.2 solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2; SLC3A2 2 6 6 NM_018223.1 checkpoint with forkhead and ring finger domains; CHFR 2 6 7 NM_003485.3 G protein-coupled receptor 68; GPR68 2 6 8 NM_005954.2 metallothionein 3 (growth inhibitory factor (neurotrophic)); MT3 2 6 9 AK023577.1 heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) binding protein 1; HSPA5BP1 2 6 10 NM_006152.2 lymphoid-restricted membrane protein; LRMP 2 6 11 NM_005982.1 sine oculis homeobox homolog 1 (Drosophila); SIX1 2 6 12 NM_002513.2 non-metastatic cells 3, protein expressed in; NME3 2 7 1 AJ007611.1 cadherin 7, type 2; CDH7 2 7 2 AF331857.1 DNA (cytosine-5-)-methyltransferase 3 beta; DNMT3B 2 7 3 NM_004143.2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1; CITED1 2 7 4 NM_005233.3 EPH receptor A3; EPHA3 2 7 5 NM_001944.1 desmoglein 3 (pemphigus vulgaris antigen); DSG3 2 7 6 BC034349.1 tumor necrosis factor receptor superfamily, member 6b, decoy; TNFRSF6B 2 7 7 NM_000061.1 Bruton agammaglobulinemia tyrosine kinase; BTK 2 7 8 NM_000189.4 hexokinase 2; HK2 2 7 9 BC099657.1 desmoglein 2; DSG2 2 7 10 NM_003650.2 cystatin F (leukocystatin); CST7 2 7 11 NM_004065.2 cerebellar degeneration-related protein 1, 34kDa; CDR1 2 7 12 NM_002354.1 tumor-associated calcium signal transducer 1; TACSTD1 2 8 1 BT007422.1 SMAD, mothers against DPP homolog 2 (Drosophila); SMAD2 2 8 2 NM_002918.3 regulatory factor X, 1 (influences HLA class II expression); RFX1 2 8 3 AF083116.1 paraneoplastic antigen MA3; PNMA3 2 8 4 BC058883.1 dehydrogenase/reductase (SDR family) member 9; DHRS9 2 8 5 NM_006868.2 RAB31, member RAS oncogene family; RAB31 2 8 6 NM_052847.1 guanine nucleotide binding protein (G protein), gamma 7; GNG7 2 8 7 NM_014351.3 sulfotransferase family 4A, member 1; SULT4A1 2 8 8 NG_001572.1 cyclin-dependent kinase 7 pseudogene; CDK7PS 2 8 9 NM_013326.3 chromosome 18 open reading frame 8; C18orf8 2 8 10 NM_001523.1 hyaluronan synthase 1; HAS1 2 8 11 NM_001469.3 X-ray repair complementing defective repair in Chinese hamster cells 6 (Ku autoantigen, 70kDa); XRCC6 2 8 12 NM_001463.2 frizzled-related protein; FRZB 2 9 1 NM_004566.2 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3; PFKFB3 2 9 2 NM_000212.2 integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); ITGB3 2 9 3 NM_000277.1 phenylalanine hydroxylase; PAH 2 9 4 NM_002512.2 non-metastatic cells 2, protein (NM23B) expressed in; NME2 2 9 5 NM_020469.2 ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase); ABO 2 9 6 AB208913.1 integrin, beta 4; ITGB4 2 9 7 AK127851.1 active BCR-related gene; ABR 2 9 8 NM_000135.2 Fanconi anemia, complementation group A; FANCA 2 9 9 NM_001261.2 cyclin-dependent kinase 9 (CDC2-related kinase); CDK9 2 9 10 NM_006640.2 septin 9; SEPT9 2 9 11 NM_024596.1 microcephaly, primary autosomal recessive 1; MCPH1 2 9 12 NM_002781.2 pregnancy specific beta-1-glycoprotein 5; PSG5 2 10 1 NM_014580.3 solute carrier family 2, (facilitated glucose transporter) member 8; SLC2A8 2 10 2 NM_005030.3 polo-like kinase 1 (Drosophila); PLK1 2 10 3 NM_080839.4 gamma-glutamyltransferase-like 4; GGTL4 2 10 4 BC085615.1 breast cancer 1, early onset; BRCA1 2 10 5 BX649089.1 nuclear receptor subfamily 4, group A, member 3; NR4A3 2 10 6 AF055377.1 v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian); MAF 2 10 7 AL591493.14 the FCGR1A gene for Fc fragment of IgG, high affinity Ia, receptor for (CD64) 2 10 8 BC017570.1 chromosome 9 open reading frame 78; C9orf78 2 10 9 NM_002169.1 interferon, alpha 5; IFNA5 2 10 10 NM_007317.1 kinesin family member 22; KIF22 2 10 11 NM_025218.2 UL16 binding protein 1; ULBP1 2 10 12 obsaracontrol#014 control oligonucleotide 3 1 1 X63432 beta-actin, replicated spot 3 1 2 NM_007177.1 TU3A protein; TU3A 3 1 3 BC017283.1 SHC (Src homology 2 domain containing) transforming protein 1; SHC1 3 1 4 NM_000784.2 cytochrome P450, family 27, subfamily A, polypeptide 1; CYP27A1 3 1 5 NM_002048.1 growth arrest-specific 1; GAS1 3 1 6 BC016300.1 S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog); S100A4 3 1 7 NM_005957.3 5,10-methylenetetrahydrofolate reductase (NADPH); MTHFR 3 1 8 NM_000634.2 interleukin 8 receptor, alpha; IL8RA 3 1 9 NM_000094.2 collagen, type VII, alpha 1 (epidermolysis bullosa, dystrophic, dominant and recessive); COL7A1 3 1 10 NM_003598.1 TEA domain family member 2; TEAD2 3 1 11 NM_001066.2 tumor necrosis factor receptor superfamily, member 1B; TNFRSF1B 3 1 12 M26880 ubiquitin_2 3 2 1 K02777.1 Human T-cell receptor active alpha-chain mRNA from Jurkat cell line 3 2 2 NM_002201.4 interferon stimulated exonuclease gene 20kDa; ISG20 3 2 3 NM_000963.1 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase); PTGS2 3 2 4 NM_006634.2 vesicle-associated membrane protein 5 (myobrevin); VAMP5 3 2 5 NM_021141.2 X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining; Ku autoantigen, 80kDa); XRCC5 3 2 6 NM_000246.2 class II, major histocompatibility complex, transactivator; CIITA 3 2 7 BC065912.1 v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene); ABL2 3 2 8 NM_003659.2 alkylglycerone phosphate synthase; AGPS 3 2 9 NM_005246.1 fer (fps/fes related) tyrosine kinase (phosphoprotein NCP94); FER 3 2 10 NM_002502.2 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100); NFKB2 3 2 11 NM_001561.4 tumor necrosis factor receptor superfamily, member 9; TNFRSF9 3 2 12 BC031549.1 CDC-like kinase 1; CLK1 3 3 1 obsaracontrol#014 control oligonucleotide 3 3 2 NM_001964.2 early growth response 1; EGR1 3 3 3 NM_198098.1 aquaporin 1 (channel-forming integral protein, 28kDa); AQP1 3 3 4 NM_000264.2 patched homolog (Drosophila); PTCH 3 3 5 NM_006545.4 tumor suppressor candidate 4; TUSC4 3 3 6 NM_002188.2 interleukin 13; IL13 3 3 7 NM_000168.2 GLI-Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome); GLI3 3 3 8 NM_001333.2 cathepsin L2; CTSL2 3 3 9 BC000692.2 hyaluronoglucosaminidase 2; HYAL2 3 3 10 NM_013232.2 programmed cell death 6; PDCD6 3 3 11 NM_000602.1 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; SERPINE1 3 3 12 NM_003358.1 UDP-glucose ceramide glucosyltransferase; UGCG 3 4 1 NM_012191.2 N-acetyltransferase 6; NAT6 3 4 2 NM_003122.2 serine peptidase inhibitor, Kazal type 1; SPINK1 3 4 3 NM_000600.1 interleukin 6 (interferon, beta 2); IL6 3 4 4 NM_002197.1 aconitase 1, soluble; ACO1 3 4 5 BC044602.1 sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B; SEMA3B 3 4 6 NM_005733.1 kinesin family member 20A; KIF20A 3 4 7 NM_007353.2 guanine nucleotide binding protein (G protein) alpha 12; GNA12 3 4 8 NM_002170.2 interferon, alpha 8; IFNA8 3 4 9 NM_014240.1 LIM domains containing 1; LIMD1 3 4 10 NM_001025.4 ribosomal protein S23; RPS23 3 4 11 BC034376.1 amphiphysin (Stiff-Man syndrome with breast cancer 128kDa autoantigen); AMPH 3 4 12 NM_005077.3 transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila); TLE1 3 5 1 NM_000448.1 recombination activating gene 1; RAG1 3 5 2 NM_024854.2 hypothetical protein FLJ22028; FLJ22028 3 5 3 NM_004751.1 glucosaminyl (N-acetyl) transferase 3, mucin type; GCNT3 3 5 4 NM_002722.3 pancreatic polypeptide; PPY 3 5 5 NM_002422.3 matrix metallopeptidase 3 (stromelysin 1, progelatinase); MMP3 3 5 6 NM_004064.2 cyclin-dependent kinase inhibitor 1B (p27, Kip1); CDKN1B 3 5 7 NM_001003.2 ribosomal protein, large, P1; RPLP1 3 5 8 NM_015343.3 dullard homolog (Xenopus laevis); DULLARD 3 5 9 AY660536.1 caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase); CASP1 3 5 10 NM_000619.2 interferon, gamma; IFNG 3 5 11 NM_000750.2 cholinergic receptor, nicotinic, beta polypeptide 4; CHRNB4 3 5 12 BC046099.1 TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa; TAF15 3 6 1 AK095388.1 MRE11 meiotic recombination 11 homolog A (S. cerevisiae); MRE11A 3 6 2 BT020093.1 RAP1B, member of RAS oncogene family; RAP1B 3 6 3 BC035959.1 cytochrome P450, family 19, subfamily A, polypeptide 1; CYP19A1 3 6 4 BC019040.2 peripheral myelin protein 22; PMP22 3 6 5 AC090835.7 Homo sapiens chromosome 11, clone RP11-7O20, complete sequence;; 3 6 6 NM_000239.1 lysozyme (renal amyloidosis); LYZ 3 6 7 BT019705.1 RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae); RAD51 3 6 8 AY613431.1 growth hormone 1; GH1 3 6 9 AY525610.1 Homo sapiens progesterone receptor (PGR) gene, complete cds; 3 6 10 BC000254.1 activin A receptor, type IB; ACVR1B 3 6 11 NM_006293.2 TYRO3 protein tyrosine kinase; TYRO3 3 6 12 NM_001383.2 DPH1 homolog (S. cerevisiae); DPH1 3 7 1 DQ223012.1 kallikrein 6 (neurosin, zyme); KLK6 3 7 2 BC108315.1 GNAS complex locus; GNAS 3 7 3 NM_002365.3 melanoma antigen family B, 3; MAGEB3 3 7 4 NM_001039499.1 prostate androgen-regulated transcript 1; PART1 3 7 5 NM_002975.2 C-type lectin domain family 11, member A; CLEC11A 3 7 6 NM_000915.2 oxytocin, prepro- (neurophysin I); OXT 3 7 7 NM_000475.3 nuclear receptor subfamily 0, group B, member 1; NR0B1 3 7 8 NM_006206.3 platelet-derived growth factor receptor, alpha polypeptide; PDGFRA 3 7 9 NM_006270.2 related RAS viral (r-ras) oncogene homolog; RRAS 3 7 10 BT019496.1 prion protein (p27-30) (Creutzfeld-Jakob disease, Gerstmann-Strausler-Scheinker syndrome, fatal familial insomnia); PRNP 3 7 11 BC094758.1 dystrophin (muscular dystrophy, Duchenne and Becker types); DMD 3 7 12 NM_001553.1 insulin-like growth factor binding protein 7; IGFBP7 3 8 1 NM_003950.2 coagulation factor II (thrombin) receptor-like 3; F2RL3 3 8 2 NM_003222.3 transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma); TFAP2C 3 8 3 NM_000133.2 coagulation factor IX (plasma thromboplastic component, Christmas disease, hemophilia B); F9 3 8 4 NM_013230.2 CD24 antigen (small cell lung carcinoma cluster 4 antigen); CD24 3 8 5 NM_020309.2 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7; SLC17A7 3 8 6 NM_002165.2 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein; ID1 3 8 7 NM_004615.2 tetraspanin 7; TSPAN7 3 8 8 NM_012110.2 cysteine-rich hydrophobic domain 2; CHIC2 3 8 9 NM_000641.2 interleukin 11; IL11 3 8 10 NM_002999.2 syndecan 4 (amphiglycan, ryudocan); SDC4 3 8 11 NM_005462.3 melanoma antigen family C, 1; MAGEC1 3 8 12 NM_004628.3 xeroderma pigmentosum, complementation group C; XPC 3 9 1 NM_002007.1 fibroblast growth factor 4 (heparin secretory transforming protein 1, Kaposi sarcoma oncogene); FGF4 3 9 2 NM_002967.2 scaffold attachment factor B; SAFB 3 9 3 AF370435.1 Homo sapiens PP9932 mRNA, complete cds;; 3 9 4 NM_004393.1 dystroglycan 1 (dystrophin-associated glycoprotein 1); DAG1 3 9 5 NM_021975.2 v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian); RELA 3 9 6 NM_002691.1 polymerase (DNA directed), delta 1, catalytic subunit 125kDa; POLD1 3 9 7 NM_001792.2 cadherin 2, type 1, N-cadherin (neuronal); CDH2 3 9 8 NG_000019.3 Homo sapiens chorionic gonadotropin beta region (CGB@) on chromosome 19; ; 3 9 9 NM_003793.3 cathepsin F; CTSF 3 9 10 AC092066.4 Homo sapiens chromosome 19 clone CTB-171A8, complete sequence;; 3 9 11 NM_002823.2 prothymosin, alpha (gene sequence 28); PTMA 3 9 12 NM_002729.3 hematopoietically expressed homeobox; HHEX 3 10 1 obsaracontrol#015 control oligonucleotide 3 10 2 NM_005215.1 deleted in colorectal carcinoma; DCC 3 10 3 BC068545.1 exostoses (multiple) 2; EXT2 3 10 4 X59847.1 L1 cell adhesion molecule; L1CAM 3 10 5 NM_014333.2 immunoglobulin superfamily, member 4; IGSF4 3 10 6 NM_000367.2 thiopurine S-methyltransferase; TPMT 3 10 7 AF124540.1 tumor protein p73-like; TP73L 3 10 8 U82671.5 Homo sapiens chromosome X multiple clones map q28, complete sequence;; 3 10 9 AY796203.1 Homo sapiens cytochrome P450, family 2, subfamily C, polypeptide 19 (CYP2C19) gene, complete cds;; 3 10 10 NM_003839.2 tumor necrosis factor receptor superfamily, member 11a, NFKB activator; TNFRSF11A 3 10 11 NM_000021.2 presenilin 1 (Alzheimer disease 3); PSEN1 3 10 12 NM_005138.1 SCO cytochrome oxidase deficient homolog 2 (yeast); SCO2 4 1 1 L25899 Ribosomal protein L10 4 1 2 NM_005869.2 serologically defined colon cancer antigen 10; SDCCAG10 4 1 3 BC041121.1 aryl hydrocarbon receptor nuclear translocator; ARNT 4 1 4 NM_007115.2 tumor necrosis factor, alpha-induced protein 6; TNFAIP6 4 1 5 NM_001770.4 CD19 antigen; CD19 4 1 6 NM_002416.1 chemokine (C-X-C motif) ligand 9; CXCL9 4 1 7 NM_003567.2 breast cancer anti-estrogen resistance 3; BCAR3 4 1 8 NM_003236.1 transforming growth factor, alpha; TGFA 4 1 9 NM_002315.1 LIM domain only 1 (rhombotin 1); LMO1 4 1 10 NM_000266.1 Norrie disease (pseudoglioma); NDP 4 1 11 BC039146.1 CD34 antigen; CD34 4 1 12 L25899 Ribosomal protein L10 4 2 1 NM_005583.3 lymphoblastic leukemia derived sequence 1; LYL1 4 2 2 CR624145.1 full-length cDNA clone CS0DJ007YD24 of T cells (Jurkat cell line) Cot 10-normalized of Homo sapiens (human); 4 2 3 BC028126.2 bromodomain, testis-specific; BRDT 4 2 4 NM_006226.1 phospholipase C-like 1; PLCL1 4 2 5 BC040168.1 v-ets erythroblastosis virus E26 oncogene like (avian); ERG 4 2 6 AJ010098.1 TYRO protein tyrosine kinase binding protein; TYROBP 4 2 7 AF543826.1 Fc fragment of IgG, low affinity IIb, receptor (CD32) 4 2 8 NM_000251.1 mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli); MSH2 4 2 9 BC107069.1 v-abl Abelson murine leukemia viral oncogene homolog 1; ABL1 4 2 10 NM_017432.2 prostate tumor overexpressed gene 1; PTOV1 4 2 11 NM_015991.2 complement component 1, q subcomponent, alpha polypeptide; C1QA 4 2 12 NM_002759.1 eukaryotic translation initiation factor 2-alpha kinase 2; EIF2AK2 4 3 1 NM_005245.3 FAT tumor suppressor homolog 1 (Drosophila); FAT 4 3 2 obsaracontrol#015 control oligonucleotide 4 3 3 NM_004225.1 malignant fibrous histiocytoma amplified sequence 1; MFHAS1 4 3 4 NM_000124.1 excision repair cross-complementing rodent repair deficiency, complementation group 6; ERCC6 4 3 5 NM_004181.3 ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase); UCHL1 4 3 6 NM_002377.2 MAS1 oncogene; MAS1 4 3 7 NM_005195.2 CCAAT/enhancer binding protein (C/EBP), delta; CEBPD 4 3 8 NM_005063.4 stearoyl-CoA desaturase (delta-9-desaturase); SCD 4 3 9 NM_006342.1 transforming, acidic coiled-coil containing protein 3; TACC3 4 3 10 NM_005104.2 bromodomain containing 2; BRD2 4 3 11 NM_005273.2 guanine nucleotide binding protein (G protein), beta polypeptide 2; GNB2 4 3 12 BC001322.1 annexin A7; ANXA7 4 4 1 BC098400.1 C-terminal binding protein 1; CTBP1 4 4 2 NM_004557.3 Notch homolog 4 (Drosophila); NOTCH4 4 4 3 NM_004444.4 EPH receptor B4; EPHB4 4 4 4 BC012920.1 deoxynucleotidyltransferase, terminal; DNTT 4 4 5 AY600371.1 Homo sapiens replication factor C (activator 1) 1, 145kDa (RFC1) gene, complete cds; 4 4 6 AY755627.1 advanced glycosylation end product-specific receptor; AGER 4 4 7 NM_001621.3 aryl hydrocarbon receptor; AHR 4 4 8 NM_005564.2 lipocalin 2 (oncogene 24p3); LCN2 4 4 9 NM_002111.6 huntingtin (Huntington disease); HD 4 4 10 NM_000063.3 complement component 2; C2 4 4 11 NM_001742.2 calcitonin receptor; CALCR 4 4 12 NM_004486.4 golgi autoantigen, golgin subfamily a, 2; GOLGA2 4 5 1 X68149.1 Burkitt lymphoma receptor 1, GTP binding protein (chemokine (C-X-C motif) receptor 5); BLR1 4 5 2 NM_002298.2 lymphocyte cytosolic protein 1 (L-plastin); LCP1 4 5 3 NM_000499.2 cytochrome P450, family 1, subfamily A, polypeptide 1; CYP1A1 4 5 4 NM_021137.3 tumor necrosis factor, alpha-induced protein 1 (endothelial); TNFAIP1 4 5 5 NM_000039.1 apolipoprotein A-I; APOA1 4 5 6 BC037491.2 ligase IV, DNA, ATP-dependent; LIG4 4 5 7 NM_006122.2 mannosidase, alpha, class 2A, member 2; MAN2A2 4 5 8 BC001769.1 TNF receptor-associated factor 4; TRAF4 4 5 9 NM_004111.4 flap structure-specific endonuclease 1; FEN1 4 5 10 NM_004951.3 Epstein-Barr virus induced gene 2 (lymphocyte-specific G protein-coupled receptor); EBI2 4 5 11 NM_003870.3 IQ motif containing GTPase activating protein 1; IQGAP1 4 5 12 AC004526.1 Homo sapiens chromosome 17, Neurofibromatosis 1 locus, complete sequence;; 4 6 1 NM_001404.4 eukaryotic translation elongation factor 1 gamma; EEF1G 4 6 2 NM_005171.2 activating transcription factor 1; ATF1 4 6 3 NM_005928.1 milk fat globule-EGF factor 8 protein; MFGE8 4 6 4 NM_018428.2 chromosome 17 open reading frame 40; C17orf40 4 6 5 NM_000612.2 insulin-like growth factor 2 (somatomedin A); IGF2 4 6 6 NM_006861.4 RAB35, member RAS oncogene family; RAB35 4 6 7 NM_005902.3 SMAD, mothers against DPP homolog 3 (Drosophila); SMAD3 4 6 8 NM_005568.2 LIM homeobox 1; LHX1 4 6 9 NM_000852.2 glutathione S-transferase pi; GSTP1 4 6 10 NM_012240.1 sirtuin (silent mating type information regulation 2 homolog) 4 (S. cerevisiae); SIRT4 4 6 11 NM_005078.1 transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila); TLE3 4 6 12 AB209658.1 integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor); ITGA3 4 7 1 NM_000836.1 glutamate receptor, ionotropic, N-methyl D-aspartate 2D; GRIN2D 4 7 2 NM_003225.2 trefoil factor 1 (breast cancer, estrogen-inducible sequence expressed in); TFF1 4 7 3 NM_018194.1 hedgehog acyltransferase; HHAT 4 7 4 AC083884.6 Homo sapiens BAC clone RP11-813J7 from 7, complete sequence;; 4 7 5 NM_004283.2 RAB3D, member RAS oncogene family; RAB3D 4 7 6 BC014453.1 beta-site APP-cleaving enzyme 2; BACE2 4 7 7 NM_003140.1 sex determining region Y; SRY 4 7 8 BC041364.1 PMS2-C terminal-like; PMS2CL 4 7 9 NM_018687.3 hepatocellular carcinoma-associated gene TD26; LOC55908 4 7 10 NM_005239.4 v-ets erythroblastosis virus E26 oncogene homolog 2 (avian); ETS2 4 7 11 NM_016249.2 melanoma antigen family C, 2; MAGEC2 4 7 12 AC073139.6 Homo sapiens BAC clone RP11-718D16 from 7, complete sequence; ; 4 8 1 NM_001299.4 calponin 1, basic, smooth muscle; CNN1 4 8 2 NM_014586.1 hormonally upregulated Neu-associated kinase; HUNK 4 8 3 BT019601.1 proteolipid protein 1 (Pelizaeus-Merzbacher disease, spastic paraplegia 2, uncomplicated); PLP1 4 8 4 NM_002356.4 myristoylated alanine-rich protein kinase C substrate; MARCKS 4 8 5 NM_002229.2 jun B proto-oncogene; JUNB 4 8 6 NM_003253.1 T-cell lymphoma invasion and metastasis 1; TIAM1 4 8 7 NM_021120.1 discs, large homolog 3 (neuroendocrine-dlg, Drosophila); DLG3 4 8 8 BC000312.2 cyclin-dependent kinase inhibitor 1A (p21, Cip1); CDKN1A 4 8 9 NM_006397.2 ribonuclease H2, large subunit; RNASEH2A 4 8 10 NM_007038.2 ADAM metallopeptidase with thrombospondin type 1 motif, 5 (aggrecanase-2); ADAMTS5 4 8 11 NM_003254.2 TIMP metallopeptidase inhibitor 1; TIMP1 4 8 12 NM_021977.2 solute carrier family 22 (extraneuronal monoamine transporter), member 3; SLC22A3 4 9 1 BT007258.1 Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse); MDM2 4 9 2 NM_014577.1 bromodomain containing 1; BRD1 4 9 3 NM_016192.2 transmembrane protein with EGF-like and two follistatin-like domains 2; TMEFF2 4 9 4 NM_006235.1 POU domain, class 2, associating factor 1; POU2AF1 4 9 5 NM_006325.2 RAN, member RAS oncogene family; RAN 4 9 6 BC103891.1 Homo sapiens cDNA clone MGC:119266 IMAGE:40005052, complete cds;; 4 9 7 Y00638.1 protein tyrosine phosphatase, receptor type, C; PTPRC 4 9 8 BC029812.1 zinc finger and BTB domain containing 16; ZBTB16 4 9 9 NM_004990.2 methionine-tRNA synthetase; MARS 4 9 10 NM_001187.1 B melanoma antigen; BAGE 4 9 11 BC058831.1 von Hippel-Lindau tumor suppressor; VHL 4 9 12 Y13620.1 B-cell CLL/lymphoma 9; BCL9 4 10 1 M26880 ubiquitin_2 4 10 2 obsaracontrol#014 control oligonucleotide 4 10 3 NM_005514.5 major histocompatibility complex, class I, B; HLA-B 4 10 4 NM_030756.1 transcription factor 7-like 2 (T-cell specific, HMG-box); TCF7L2 4 10 5 NM_006838.2 methionyl aminopeptidase 2; METAP2 4 10 6 NM_012112.4 TPX2, microtubule-associated, homolog (Xenopus laevis); TPX2 4 10 7 CR456954.1 homeo box C6; HOXC6 4 10 8 NM_005431.1 X-ray repair complementing defective repair in Chinese hamster cells 2; XRCC2 4 10 9 NM_000932.1 phospholipase C, beta 3 (phosphatidylinositol-specific); PLCB3 4 10 10 NM_015596.1 kallikrein 13; KLK13 4 10 11 NM_005532.3 interferon, alpha-inducible protein 27; IFI27 4 10 12 M26880 ubiquitin_2 5 1 1 X01677 glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA, complete cds; glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12), replicated spot 5 1 2 NM_002006.3 fibroblast growth factor 2 (basic); FGF2 5 1 3 NM_005269.1 glioma-associated oncogene homolog 1 (zinc finger protein); GLI1 5 1 4 NM_003326.2 tumor necrosis factor (ligand) superfamily, member 4 (tax-transcriptionally activated glycoprotein 1, 34kDa); TNFSF4 5 1 5 BC092449.1 immunoglobulin heavy constant alpha 1; IGHA1 5 1 6 NM_003011.1 SET translocation (myeloid leukemia-associated); SET 5 1 7 NM_001035258.1 ribosomal protein L38; RPL38 5 1 8 NM_000858.4 guanylate kinase 1; GUK1 5 1 9 NM_005665.4 ecotropic viral integration site 5; EVI5 5 1 10 X16323.1 hepatocyte growth factor (hepapoietin A; scatter factor); HGF 5 1 11 BC035313.1 ribosomal protein S29; RPS29 5 1 12 BT019494.1 death associated protein 3; DAP3 5 2 1 NM_018411.3 hairless homolog (mouse); HR 5 2 2 NM_001040075.1 Homo sapiens similar to Ig kappa chain V-II region RPMI 6410 precursor (LOC651928), mRNA; ; 5 2 3 NM_001444.1 fatty acid binding protein 5 (psoriasis-associated); FABP5 5 2 4 NM_012152.1 endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7; EDG7 5 2 5 NM_005432.2 X-ray repair complementing defective repair in Chinese hamster cells 3; XRCC3 5 2 6 M55406.1 mucin 3A, intestinal; MUC3A 5 2 7 U74301.1 Fas (TNFRSF6)-associated via death domain; FADD 5 2 8 NM_000081.2 lysosomal trafficking regulator; LYST 5 2 9 NM_016155.3 matrix metallopeptidase 17 (membrane-inserted); MMP17 5 2 10 NM_001790.2 cell division cycle 25C; CDC25C 5 2 11 AF238378.5 Homo sapiens chromosome 8 clone SCb-561b17 map p23.1, complete sequence; ; 5 2 12 NM_005424.2 tyrosine kinase with immunoglobulin-like and EGF-like domains 1; TIE1 5 3 1 NM_001640.3 N-acylaminoacyl-peptide hydrolase; APEH 5 3 2 NM_001775.2 CD38 antigen (p45); CD38 5 3 3 NM_001512.2 glutathione S-transferase A4; GSTA4 5 3 4 NM_005382.1 neurofilament 3 (150kDa medium); NEF3 5 3 5 BC082764.1 eukaryotic translation initiation factor 4 gamma, 1; EIF4G1 5 3 6 NM_000222.1 v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; KIT 5 3 7 NM_003221.2 transcription factor AP-2 beta (activating enhancer binding protein 2 beta); TFAP2B 5 3 8 NM_021020.1 leucine zipper, putative tumor suppressor 1; LZTS1 5 3 9 NM_016206.2 vestigial-like 3; VGL-3 5 3 10 NM_021159.3 RAP1, GTP-GDP dissociation stimulator 1; RAP1GDS1 5 3 11 NM_002648.2 pim-1 oncogene; PIM1 5 3 12 NM_002865.1 RAB2, member RAS oncogene family; RAB2 5 4 1 NM_001063.2 transferrin; TF 5 4 2 NM_014395.1 dual adaptor of phosphotyrosine and 3-phosphoinositides; DAPP1 5 4 3 NM_013352.1 squamous cell carcinoma antigen recognized by T cells 2; SART2 5 4 4 BC019588.2 clusterin (complement lysis inhibitor, SP-40,40, sulfated glycoprotein 2, testosterone-repressed prostate message 2, apolipoprotein J); CLU 5 4 5 NM_003234.1 transferrin receptor (p90, CD71); TFRC 5 4 6 NM_001432.1 epiregulin; EREG 5 4 7 AK056699.1 FYN oncogene related to SRC, FGR, YES; FYN 5 4 8 NM_001772.2 CD33 antigen (gp67); CD33 5 4 9 NM_006773.3 DEAD (Asp-Glu-Ala-Asp) box polypeptide 18; DDX18 5 4 10 AF385628.2 interleukin 8; IL8 5 4 11 BC109085.1 pleiomorphic adenoma gene-like 1; PLAGL1 5 4 12 U29105.1 steroidogenic acute regulator; STAR 5 5 1 obsaracontrol#015 control oligonucleotide 5 5 2 NM_004561.2 ovo-like 1(Drosophila); OVOL1 5 5 3 NM_005845.2 ATP-binding cassette, sub-family C (CFTR/MRP), member 4; ABCC4 5 5 4 NM_001793.3 cadherin 3, type 1, P-cadherin (placental); CDH3 5 5 5 NM_012238.3 sirtuin (silent mating type information regulation 2 homolog) 1 (S. cerevisiae); SIRT1 5 5 6 NM_020404.2 CD248 antigen, endosialin; CD248 5 5 7 NM_004128.1 general transcription factor IIF, polypeptide 2, 30kDa; GTF2F2 5 5 8 NM_021197.2 WAP four-disulfide core domain 1; WFDC1 5 5 9 BC020057.1 integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12); ITGB1 5 5 10 NM_003311.3 pleckstrin homology-like domain, family A, member 2; PHLDA2 5 5 11 NM_004004.3 gap junction protein, beta 2, 26kDa (connexin 26); GJB2 5 5 12 NM_018975.2 telomeric repeat binding factor 2, interacting protein; TERF2IP 5 6 1 BC000311.2 Kruppel-like factor 6; KLF6 5 6 2 NM_000076.1 cyclin-dependent kinase inhibitor 1C (p57, Kip2); CDKN1C 5 6 3 NM_004294.2 mitochondrial translational release factor 1; MTRF1 5 6 4 NM_018094.2 G1 to S phase transition 2; GSPT2 5 6 5 BC014098.2 synuclein, gamma (breast cancer-specific protein 1); SNCG 5 6 6 NM_004356.3 CD81 antigen (target of antiproliferative antibody 1); CD81 5 6 7 NM_000059.2 breast cancer 2, early onset; BRCA2 5 6 8 NM_001171.2 ATP-binding cassette, sub-family C (CFTR/MRP), member 6; ABCC6 5 6 9 NM_005436.2 coiled-coil domain containing 6; CCDC6 5 6 10 BC019323.1 hydroxymethylbilane synthase; HMBS 5 6 11 NM_007106.2 ubiquitin-like 3; UBL3 5 6 12 BK001049.1 transcription factor 12 (HTF4, helix-loop-helix transcription factors 4); TCF12 5 7 1 BC001718.1 Homo sapiens v-crk sarcoma virus CT10 oncogene homolog (avian), transcript variant II, mRNA (cDNA clone MGC:3138 IMAGE:3353237), complete cds;; 5 7 2 NM_021102.2 serine peptidase inhibitor, Kunitz type, 2; SPINT2 5 7 3 NM_005940.3 matrix metallopeptidase 11 (stromelysin 3); MMP11 5 7 4 NM_003035.1 SCL/TAL1 interrupting locus; STIL 5 7 5 NM_002276.3 keratin 19; KRT19 5 7 6 AY819760.1 mucosal vascular addressin cell adhesion molecule 1; MADCAM1 5 7 7 NM_014433.2 rhabdoid tumor deletion region gene 1; RTDR1 5 7 8 NM_004102.3 fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor); FABP3 5 7 9 NM_004217.2 aurora kinase B; AURKB 5 7 10 NM_004829.4 natural cytotoxicity triggering receptor 1; NCR1 5 7 11 NM_003935.3 topoisomerase (DNA) III beta; TOP3B 5 7 12 X97198.1 protein tyrosine phosphatase, receptor type, U; PTPRU 5 8 1 NM_002903.2 recoverin; RCV1 5 8 2 NM_006732.1 FBJ murine osteosarcoma viral oncogene homolog B; FOSB 5 8 3 NM_005207.2 v-crk sarcoma virus CT10 oncogene homolog (avian)-like; CRKL 5 8 4 BC062580.1 neurotrophic tyrosine kinase, receptor, type 1; NTRK1 5 8 5 NM_003963.2 transmembrane 4 L six family member 5; TM4SF5 5 8 6 NM_002516.1 neuro-oncological ventral antigen 2; NOVA2 5 8 7 BC005867.2 catechol-O-methyltransferase; COMT 5 8 8 AF294278.1 PR domain containing 16; PRDM16 5 8 9 NM_002550.1 olfactory receptor, family 3, subfamily A, member 1; OR3A1 5 8 10 NM_015710.3 glioma tumor suppressor candidate region gene 2; GLTSCR2 5 8 11 NM_003906.3 MCM3 minichromosome maintenance deficient 3 (S. cerevisiae) associated protein; MCM3AP 5 8 12 NM_021948.3 brevican; BCAN 5 9 1 AY653072.1 estrogen receptor binding site associated, antigen, 9; EBAG9 5 9 2 NM_000538.2 regulatory factor X-associated protein; RFXAP 5 9 3 BC029891.1 transcription factor EC; TFEC 5 9 4 NM_024408.2 Notch homolog 2 (Drosophila); NOTCH2 5 9 5 NM_006904.6 protein kinase, DNA-activated, catalytic polypeptide; PRKDC 5 9 6 NM_003914.2 cyclin A1; CCNA1 5 9 7 NM_000351.3 steroid sulfatase (microsomal), arylsulfatase C, isozyme S; STS 5 9 8 NM_020208.2 solute carrier family 6 (proline IMINO transporter), member 20; SLC6A20 5 9 9 NM_001147.1 angiopoietin 2; ANGPT2 5 9 10 NM_003295.1 tumor protein, translationally-controlled 1; TPT1 5 9 11 NM_000273.1 G protein-coupled receptor 143; GPR143 5 9 12 NM_000639.1 Fas ligand (TNF superfamily, member 6); FASLG 5 10 1 K00558 Alpha tubulin_2 5 10 2 BC012863.1 forkhead box M1; FOXM1 5 10 3 AC019188.6 Homo sapiens BAC clone RP11-309H6 from 4, complete sequence; 5 10 4 NM_006271.1 S100 calcium binding protein A1; S100A1 5 10 5 NM_002690.1 polymerase (DNA directed), beta; POLB 5 10 6 AC079385.18 Homo sapiens 12q BAC RP11-482D24 (Roswell Park Cancer Institute Human BAC Library) complete sequence;; 5 10 7 NM_000402.2 glucose-6-phosphate dehydrogenase; G6PD 5 10 8 NM_004629.1 Fanconi anemia, complementation group G; FANCG 5 10 9 NM_002291.1 laminin, beta 1; LAMB1 5 10 10 NM_000618.2 insulin-like growth factor 1 (somatomedin C); IGF1 5 10 11 NM_005229.2 ELK1, member of ETS oncogene family; ELK1 5 10 12 obsaracontrol#015 control oligonucleotide 6 1 1 K00558 Alpha tubulin_2 6 1 2 NM_006766.2 MYST histone acetyltransferase (monocytic leukemia) 3; MYST3 6 1 3 BC048768.1 protein tyrosine phosphatase, receptor type, F; PTPRF 6 1 4 BC014397.1 four and a half LIM domains 2; FHL2 6 1 5 NM_000536.1 recombination activating gene 2; RAG2 6 1 6 NM_001010934.1 hepatocyte growth factor (hepapoietin A; scatter factor); HGF 6 1 7 NM_000488.2 serpin peptidase inhibitor, clade C (antithrombin), member 1; SERPINC1 6 1 8 NM_005721.3 ARP3 actin-related protein 3 homolog (yeast); ACTR3 6 1 9 NM_007145.1 zinc finger protein 146; ZNF146 6 1 10 NM_004991.1 myelodysplasia syndrome 1; MDS1 6 1 11 NM_004675.2 DIRAS family, GTP-binding RAS-like 3; DIRAS3 6 1 12 BC094743.1 alkaline phosphatase, placental (Regan isozyme); ALPP 6 2 1 BC030143.2 mucosa associated lymphoid tissue lymphoma translocation gene 1; MALT1 6 2 2 BC016314.1 X-ray repair complementing defective repair in Chinese hamster cells 4; XRCC4 6 2 3 BT007156.1 interleukin 24; IL24 6 2 4 NM_005415.3 solute carrier family 20 (phosphate transporter), member 1; SLC20A1 6 2 5 NM_000961.3 prostaglandin I2 (prostacyclin) synthase; PTGIS 6 2 6 NM_006060.2 zinc finger protein, subfamily 1A, 1 (Ikaros); ZNFN1A1 6 2 7 NM_006762.1 lysosomal associated multispanning membrane protein 5; LAPTM5 6 2 8 NM_001935.3 dipeptidylpeptidase 4 (CD26, adenosine deaminase complexing protein 2); DPP4 6 2 9 NM_018412.3 suppression of tumorigenicity 7; ST7 6 2 10 NM_207585.1 interferon (alpha, beta and omega) receptor 2; IFNAR2 6 2 11 NM_005978.3 S100 calcium binding protein A2; S100A2 6 2 12 NM_001269.2 regulator of chromosome condensation 1; RCC1 6 3 1 NM_001871.2 carboxypeptidase B1 (tissue); CPB1 6 3 2 BC010507.2 CD14 antigen; CD14 6 3 3 CR936604.1 A kinase (PRKA) anchor protein (gravin) 12; AKAP12 6 3 4 NM_004188.2 growth factor independent 1B (potential regulator of CDKN1A, translocated in CML); GFI1B 6 3 5 NM_001086.2 arylacetamide deacetylase (esterase); AADAC 6 3 6 NM_005211.2 colony stimulating factor 1 receptor, formerly McDonough feline sarcoma viral (v-fms) oncogene homolog; CSF1R 6 3 7 NM_001901.1 connective tissue growth factor; CTGF 6 3 8 NM_003878.1 gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase); GGH 6 3 9 NM_000461.3 thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian); THRB 6 3 10 AY692426.1 ADAM metallopeptidase with thrombospondin type 1 motif, 6; ADAMTS6 6 3 11 AY766116.1 vascular endothelial growth factor; VEGF 6 3 12 BC007047.1 fibrinogen-like 1; FGL1 6 4 1 NM_014890.1 downregulated in ovarian cancer 1; DOC1 6 4 2 NM_000590.1 interleukin 9; IL9 6 4 3 NM_012241.2 sirtuin (silent mating type information regulation 2 homolog) 5 (S. cerevisiae); SIRT5 6 4 4 BC001281.1 tumor necrosis factor receptor superfamily, member 10b; TNFRSF10B 6 4 5 NM_005191.2 CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); CD80 6 4 6 NM_003883.2 histone deacetylase 3; HDAC3 6 4 7 NM_005822.1 Down syndrome critical region gene 1-like 1; DSCR1L1 6 4 8 NM_000756.1 corticotropin releasing hormone; CRH 6 4 9 NM_005688.2 ATP-binding cassette, sub-family C (CFTR/MRP), member 5; ABCC5 6 4 10 AY720441.1 colony stimulating factor 2 (granulocyte-macrophage); CSF2 6 4 11 AK090516.1 tumor protein D52-like 1; TPD52L1 6 4 12 BC054511.1 deleted in liver cancer 1; DLC1 6 5 1 AC025106.8 Homo sapiens chromosome 11, clone RP11-734D5, complete sequence; ; 6 5 2 obsaracontrol#014 control oligonucleotide 6 5 3 BT009776.1 hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor); HIF1A 6 5 4 NM_002163.2 interferon regulatory factor 8; IRF8 6 5 5 NM_014488.3 RAB30, member RAS oncogene family; RAB30 6 5 6 NM_005981.3 tetraspanin 31; TSPAN31 6 5 7 BC025385.2 fucosyltransferase 8 (alpha (1,6) fucosyltransferase); FUT8 6 5 8 BC032704.1 cyclin-dependent kinase (CDC2-like) 10; CDK10 6 5 9 NM_006185.2 nuclear mitotic apparatus protein 1; NUMA1 6 5 10 NM_005859.3 purine-rich element binding protein A; PURA 6 5 11 NM_016651.4 dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis); DACT1 6 5 12 NM_001144.4 autocrine motility factor receptor; AMFR 6 6 1 BT007158.1 folate receptor 1 (adult); FOLR1 6 6 2 NM_003299.1 tumor rejection antigen (gp96) 1; TRA1 6 6 3 NM_005065.3 sel-1 suppressor of lin-12-like (C. elegans); SEL1L 6 6 4 NM_002386.2 melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor); MC1R 6 6 5 BT020007.1 peroxiredoxin 3; PRDX3 6 6 6 NM_004616.2 tetraspanin 8; TSPAN8 6 6 7 NM_006871.3 receptor-interacting serine-threonine kinase 3; RIPK3 6 6 8 BC106895.1 adenine phosphoribosyltransferase; APRT 6 6 9 BC069106.1 fibroblast growth factor 8 (androgen-induced); FGF8 6 6 10 AF187044.1 protein tyrosine phosphatase, receptor type, O; PTPRO 6 6 11 NM_001823.3 creatine kinase, brain; CKB 6 6 12 NM_001797.2 cadherin 11, type 2, OB-cadherin (osteoblast); CDH11 6 7 1 NM_007163.2 solute carrier family 14 (urea transporter), member 2; SLC14A2 6 7 2 AY364248.1 chromatin modifying protein 2A; CHMP2A 6 7 3 NM_003932.3 suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein); ST13 6 7 4 NM_001615.3 actin, gamma 2, smooth muscle, enteric; ACTG2 6 7 5 NM_005433.3 v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1; YES1 6 7 6 BC063127.1 pregnancy specific beta-1-glycoprotein 4; PSG4 6 7 7 NM_004810.2 GRB2-related adaptor protein 2; GRAP2 6 7 8 NM_003310.1 tumor suppressing subtransferable candidate 1; TSSC1 6 7 9 NM_006919.1 serpin peptidase inhibitor, clade B (ovalbumin), member 3; SERPINB3 6 7 10 NM_001771.1 CD22 antigen; CD22 6 7 11 NM_002409.3 mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase; MGAT3 6 7 12 NM_000534.3 PMS1 postmeiotic segregation increased 1 (S. cerevisiae); PMS1 6 8 1 NM_002639.2 serpin peptidase inhibitor, clade B (ovalbumin), member 5; SERPINB5 6 8 2 NM_002866.3 RAB3A, member RAS oncogene family; RAB3A 6 8 3 NM_004286.4 GTP binding protein 1; GTPBP1 6 8 4 NM_005235.1 v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian); ERBB4 6 8 5 BC027258.1 B-cell CLL/lymphoma 2; BCL2 6 8 6 NM_002777.3 proteinase 3 (serine proteinase, neutrophil, Wegener granulomatosis autoantigen); PRTN3 6 8 7 NM_002305.3 lectin, galactoside-binding, soluble, 1 (galectin 1); LGALS1 6 8 8 NM_000576.2 interleukin 1, beta; IL1B 6 8 9 BC004488.2 gastrin-releasing peptide; GRP 6 8 10 NM_006339.2 high-mobility group 20B; HMG20B 6 8 11 NM_005488.1 target of myb1 (chicken); TOM1 6 8 12 X69699.1 paired box gene 8; PAX8 6 9 1 NM_000605.2 interferon, alpha 2; IFNA2 6 9 2 BC064577.1 copine VII; CPNE7 6 9 3 NM_024518.1 UL16 binding protein 3; ULBP3 6 9 4 AC118273.4 Homo sapiens chromosome 11, clone RP11-107P7, complete sequence; ; 6 9 5 NM_004936.3 cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4); CDKN2B 6 9 6 NM_002768.1 procollagen (type III) N-endopeptidase; PCOLN3 6 9 7 AB084153.1 fibroblast growth factor receptor 2 (bacteria-expressed kinase, keratinocyte growth factor receptor, craniofacial dysostosis 1, Crouzon syndrome, Pfeiffer syndrome, Jackson-Weiss syndrome); FGFR2 6 9 8 NM_022443.2 myeloid leukemia factor 1; MLF1 6 9 9 NM_004938.2 death-associated protein kinase 1; DAPK1 6 9 10 NM_000548.2 tuberous sclerosis 2; TSC2 6 9 11 NM_018557.2 low density lipoprotein-related protein 1B (deleted in tumors); LRP1B 6 9 12 NM_001001731.1 Mahlavu hepatocellular carcinoma; HHCM 6 10 1 BC010066.2 ubiquilin 1; UBQLN1 6 10 2 BC000906.2 NAD(P)H dehydrogenase, quinone 1; NQO1 6 10 3 AC105052.3 Homo sapiens BAC clone RP11-577H5 from 7, complete sequence;; 6 10 4 BC015603.2 interferon, alpha-inducible protein (clone IFI-6-16); G1P3 6 10 5 BC063850.1 dynamin 1; DNM1 6 10 6 NM_021615.3 carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6; CHST6 6 10 7 NM_005598.2 nescient helix loop helix 1; NHLH1 6 10 8 NM_145809.1 TL132 protein; LOC220594 6 10 9 NM_006207.1 platelet-derived growth factor receptor-like; PDGFRL 6 10 10 NM_000275.1 oculocutaneous albinism II (pink-eye dilution homolog, mouse); OCA2 6 10 11 NM_174961.2 synovial sarcoma, X breakpoint 8; SSX8 6 10 12 obsaracontrol#014 control oligonucleotide 7 1 1 NM_005649.2 zinc finger protein 354A; ZNF354A 7 1 2 BC061890.1 Homo sapiens ribosomal protein L35a, mRNA (cDNA clone MGC:74787 IMAGE:5185135), complete cds; 7 1 3 NM_002871.3 RAB interacting factor; RABIF 7 1 4 NM_032977.2 caspase 10, apoptosis-related cysteine peptidase; CASP10 7 1 5 D89621.1 glycoprotein IX (platelet); GP9 7 1 6 NM_002881.2 v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein); RALB 7 1 7 NM_007053.2 CD160 antigen; CD160 7 1 8 AB002334.1 GRIP and coiled-coil domain containing 2; GCC2 7 1 9 DQ473645.1 Homo sapiens NADH dehydrogenase subunit 2 (ND2) gene, partial cds; mitochondrial; ; 7 1 10 BC101186.1 v-myb myeloblastosis viral oncogene homolog (avian)-like 1; MYBL1 7 1 11 NM_005248.1 Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog; FGR 7 1 12 M26880 ubiquitin_2 7 2 1 NM_000707.2 arginine vasopressin receptor 1B; AVPR1B 7 2 2 NM_152263.1 tropomyosin 3; TPM3 7 2 3 NM_001924.2 growth arrest and DNA-damage-inducible, alpha; GADD45A 7 2 4 DQ232851.1 tumor protein p53 inducible protein 3; TP53I3 7 2 5 NM_004397.3 DEAD (Asp-Glu-Ala-Asp) box polypeptide 6; DDX6 7 2 6 NM_000732.3 CD3D antigen, delta polypeptide (TiT3 complex); CD3D 7 2 7 NM_005727.2 tetraspanin 1; TSPAN1 7 2 8 NM_016252.2 baculoviral IAP repeat-containing 6 (apollon); BIRC6 7 2 9 NM_005204.2 mitogen-activated protein kinase kinase kinase 8; MAP3K8 7 2 10 NM_002880.2 v-raf-1 murine leukemia viral oncogene homolog 1; RAF1 7 2 11 BT019532.1 tumor necrosis factor receptor superfamily, member 18; TNFRSF18 7 2 12 NM_006507.2 regenerating islet-derived 1 beta (pancreatic stone protein, pancreatic thread protein); REG1B 7 3 1 NM_004624.2 vasoactive intestinal peptide receptor 1; VIPR1 7 3 2 NM_002439.2 mutS homolog 3 (E. coli); MSH3 7 3 3 NM_005228.3 epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); EGFR 7 3 4 NM_000459.2 TEK tyrosine kinase, endothelial (venous malformations, multiple cutaneous and mucosal); TEK 7 3 5 NM_003157.1 NIMA (never in mitosis gene a)-related kinase 4; NEK4 7 3 6 AY358590.1 type 1 tumor necrosis factor receptor shedding aminopeptidase regulator; ARTS-1 7 3 7 NM_005631.3 smoothened homolog (Drosophila); SMO 7 3 8 BC030600.1 nuclear receptor subfamily 6, group A, member 1; NR6A1 7 3 9 NM_000249.2 mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli); MLH1 7 3 10 NM_000038.3 adenomatosis polyposis coli; APC 7 3 11 NM_006379.2 sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C; SEMA3C 7 3 12 NM_004148.2 ninjurin 1; NINJ1 7 4 1 NM_003810.2 tumor necrosis factor (ligand) superfamily, member 10; TNFSF10 7 4 2 BT019505.1 CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); CD74 7 4 3 BT019685.1 insulin-like growth factor binding protein 1; IGFBP1 7 4 4 NM_017418.1 deleted in esophageal cancer 1; 7 4 5 NM_021101.3 claudin 1; CLDN1 7 4 6 NM_016218.1 polymerase (DNA directed) kappa; POLK 7 4 7 AK126885.1 ATP-binding cassette, sub-family B (MDR/TAP), member 8; ABCB8 7 4 8 NM_006195.4 pre-B-cell leukemia transcription factor 3; PBX3 7 4 9 NM_005929.3 antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5; MFI2 7 4 10 NM_001992.2 coagulation factor II (thrombin) receptor; F2R 7 4 11 AY691946.1 tissue factor pathway inhibitor 2; TFPI2 7 4 12 NM_002177.1 interferon, omega 1; IFNW1 7 5 1 NM_015313.1 Rho guanine nucleotide exchange factor (GEF) 12; ARHGEF12 7 5 2 NM_016293.2 bridging integrator 2; BIN2 7 5 3 NM_020529.1 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha; NFKBIA 7 5 4 AY450308.1 neighbor of BRCA1 gene 1; NBR1 7 5 5 NM_003120.1 spleen focus forming virus (SFFV) proviral integration oncogene spi1; SPI1 7 5 6 NM_003877.3 suppressor of cytokine signaling 2; SOCS2 7 5 7 BC010458.1 NDRG family member 2; NDRG2 7 5 8 NM_006373.2 vesicle amine transport protein 1 homolog (T californica); VAT1 7 5 9 NM_000107.1 damage-specific DNA binding protein 2, 48kDa; DDB2 7 5 10 NM_006163.1 nuclear factor (erythroid-derived 2), 45kDa; NFE2 7 5 11 BT020133.1 APEX nuclease (multifunctional DNA repair enzyme) 1; APEX1 7 5 12 NM_003766.2 beclin 1 (coiled-coil, myosin-like BCL2 interacting protein); BECN1 7 6 1 NM_012193.2 frizzled homolog 4 (Drosophila); FZD4 7 6 2 NM_005337.3 NCK-associated protein 1-like; NCKAP1L 7 6 3 NM_000624.3 serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5; SERPINA5 7 6 4 AK093838.1 mitogen-activated protein kinase kinase 3; MAP2K3 7 6 5 NM_003475.2 Ras association (RalGDS/AF-6) domain family 7; RASSF7 7 6 6 NM_005430.2 wingless-type MMTV integration site family, member 1; WNT1 7 6 7 BC071637.1 BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae); BRF1 7 6 8 NM_005567.2 lectin, galactoside-binding, soluble, 3 binding protein; LGALS3BP 7 6 9 NM_015855.3 Wilms tumor upstream neighbor 1; WIT1 7 6 10 NM_005379.2 myosin IA; MYO1A 7 6 11 NM_194278.2 chromosome 14 open reading frame 43; C14orf43 7 6 12 NM_014520.1 MYB binding protein (P160) 1a; MYBBP1A 7 7 1 BC003012.1 sirtuin (silent mating type information regulation 2 homolog) 2 (S. cerevisiae); SIRT2 7 7 2 CR617136.1 serine incorporator 3; SERINC3 7 7 3 BC030230.2 aminolevulinate, delta-, synthase 2 (sideroblastic/hypochromic anemia); ALAS2 7 7 4 NM_002841.2 protein tyrosine phosphatase, receptor type, G; PTPRG 7 7 5 NM_001024912.1 carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein); CEACAM1 7 7 6 AL034423.21 Human DNA sequence from clone RP5-1185N5 on chromosome 20q13.11-13.2 Contains the UBE2V1 gene for ubiquitin-conjugating enzyme E2 variant 1 and two CpG islands, complete sequence;; 7 7 7 NM_006875.2 pim-2 oncogene; PIM2 7 7 8 NM_000412.2 histidine-rich glycoprotein; HRG 7 7 9 NM_005234.3 nuclear receptor subfamily 2, group F, member 6; NR2F6 7 7 10 NM_002466.2 v-myb myeloblastosis viral oncogene homolog (avian)-like 2; MYBL2 7 7 11 AC142497.3 Homo sapiens chromosome X clone RP11-959H17 map p11.23, complete sequence; ; 7 7 12 NM_002670.1 plastin 1 (I isoform); PLS1 7 8 1 obsaracontrol#014 control oligonucleotide 7 8 2 NM_001672.2 agouti signaling protein, nonagouti homolog (mouse); ASIP 7 8 3 NM_000377.1 Wiskott-Aldrich syndrome (eczema-thrombocytopenia); WAS 7 8 4 NM_000096.1 ceruloplasmin (ferroxidase); CP 7 8 5 NM_006509.2 v-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (avian); RELB 7 8 6 AF220416.1 Homo sapiens hepatocellular carcinoma-associated antigen 58 (HCA58) mRNA, complete cds;; 7 8 7 CR594675.1 full-length cDNA clone CS0DI079YI02 of Placenta Cot 25-normalized of Homo sapiens (human); ; 7 8 8 BC065243.1 microphthalmia-associated transcription factor; MITF 7 8 9 NM_002856.1 poliovirus receptor-related 2 (herpesvirus entry mediator B); PVRL2 7 8 10 NM_020673.2 RAB22A, member RAS oncogene family; RAB22A 7 8 11 NM_001504.1 chemokine (C-X-C motif) receptor 3; CXCR3 7 8 12 NM_002343.2 lactotransferrin; LTF 7 9 1 AJ297935.1 deleted in malignant brain tumors 1; DMBT1 7 9 2 NM_001050.2 somatostatin receptor 2; SSTR2 7 9 3 BT007096.1 cytochrome b-561; CYB561 7 9 4 NM_024298.2 leukocyte receptor cluster (LRC) member 4; LENG4 7 9 5 AY675092.1 calcium channel, voltage-dependent, beta 2 subunit; CACNB2 7 9 6 BC012327.1 v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian); MAFG 7 9 7 BC029365.1 chorionic somatomammotropin hormone-like 1; CSHL1 7 9 8 NM_003785.3 P antigen family, member 1 (prostate associated); PAGE1 7 9 9 AL117410.1 supervillin; SVIL 7 9 10 NM_000226.2 keratin 9 (epidermolytic palmoplantar keratoderma); KRT9 7 9 11 BC052558.1 annexin A2; ANXA2 7 9 12 BC033755.1 CD6 antigen; CD6 7 10 1 L25899 Ribosomal protein L10 7 10 2 NM_003644.2 growth arrest-specific 7; GAS7 7 10 3 NM_016166.1 protein inhibitor of activated STAT, 1; PIAS1 7 10 4 NM_018127.4 elaC homolog 2 (E. coli); ELAC2 7 10 5 NM_003577.2 undifferentiated embryonic cell transcription factor 1; UTF1 7 10 6 NM_000088.2 collagen, type I, alpha 1; COL1A1 7 10 7 NM_001331.1 catenin (cadherin-associated protein), delta 1; CTNND1 7 10 8 BC044862.1 macrophage stimulating 1 (hepatocyte growth factor-like); MST1 7 10 9 BC002514.2 Hermansky-Pudlak syndrome 1; HPS1 7 10 10 NM_000413.1 hydroxysteroid (17-beta) dehydrogenase 1; HSD17B1 7 10 11 NM_022337.1 RAB38, member RAS oncogene family; RAB38 7 10 12 NM_003088.2 fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus); FSCN1 8 1 1 NM_001145.2 angiogenin, ribonuclease, RNase A family, 5; ANG 8 1 2 BC009026.1 ligase III, DNA, ATP-dependent; LIG3 8 1 3 NM_002923.1 regulator of G-protein signalling 2, 24kDa; RGS2 8 1 4 BT019509.1 cAMP responsive element binding protein 1; CREB1 8 1 5 NM_000207.1 insulin; INS 8 1 6 BC020692.1 deleted in lymphocytic leukemia, 1; DLEU1 8 1 7 NM_002497.2 NIMA (never in mitosis gene a)-related kinase 2; NEK2 8 1 8 NM_004525.1 low density lipoprotein-related protein 2; LRP2 8 1 9 BC041017.1 EPH receptor B2; EPHB2 8 1 10 NM_000073.1 CD3G antigen, gamma polypeptide (TiT3 complex); CD3G 8 1 11 NM_012089.1 ATP-binding cassette, sub-family B (MDR/TAP), member 10; ABCB10 8 1 12 X01677 glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA, complete cds; glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12), replicated spot 8 2 1 NM_000193.2 sonic hedgehog homolog (Drosophila); SHH 8 2 2 AL353732.14 Human DNA sequence from clone RP11-354P17 on chromosome 9 Contains the IFNA6 gene for interferon, alpha 6, the IFNA13 gene for interferon, alpha 13, the IFNA2 gene for interferon, alpha 2, the IFNA8 gene for interferon, alpha 8, an interferon, omega 1 (IF 8 2 3 NM_004578.2 RAB4A, member RAS oncogene family; RAB4A 8 2 4 NM_005378.4 v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian); MYCN 8 2 5 BC002635.1 colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage); CSF2RA 8 2 6 NM_004887.3 chemokine (C-X-C motif) ligand 14; CXCL14 8 2 7 NM_001554.3 cysteine-rich, angiogenic inducer, 61; CYR61 8 2 8 NM_004939.1 DEAD (Asp-Glu-Ala-Asp) box polypeptide 1; DDX1 8 2 9 NM_002457.1 mucin 2, intestinal/tracheal; MUC2 8 2 10 NM_002358.2 MAD2 mitotic arrest deficient-like 1 (yeast); MAD2L1 8 2 11 NM_000911.3 opioid receptor, delta 1; OPRD1 8 2 12 NM_002191.2 inhibin, alpha; INHA 8 3 1 NM_001203.1 bone morphogenetic protein receptor, type IB; BMPR1B 8 3 2 NM_006295.2 valyl-tRNA synthetase; VARS 8 3 3 NM_002553.2 origin recognition complex, subunit 5-like (yeast); ORC5L 8 3 4 NM_004529.1 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3; MLLT3 8 3 5 AY392011.1 gonadotropin-releasing hormone receptor; GNRHR 8 3 6 NM_005007.2 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1; NFKBIL1 8 3 7 NM_002214.2 integrin, beta 8; ITGB8 8 3 8 NM_003172.2 surfeit 1; SURF1 8 3 9 NM_000586.2 interleukin 2; IL2 8 3 10 AF001450.1 runt-related transcription factor 2; RUNX2 8 3 11 NM_000441.1 solute carrier family 26, member 4; SLC26A4 8 3 12 S76992.1 vav 2 oncogene; VAV2 8 4 1 NM_001237.2 cyclin A2; CCNA2 8 4 2 NM_002224.1 inositol 1,4,5-triphosphate receptor, type 3; ITPR3 8 4 3 NM_006024.4 Tax1 (human T-cell leukemia virus type I) binding protein 1; TAX1BP1 8 4 4 NM_014618.1 deleted in bladder cancer 1; DBC1 8 4 5 NM_006345.3 solute carrier family 30 (zinc transporter), member 9; SLC30A9 8 4 6 NM_004849.2 ATG5 autophagy related 5 homolog (S. cerevisiae); ATG5 8 4 7 NM_152739.3 homeo box A9; HOXA9 8 4 8 BT020119.1 protein phosphatase 2A, regulatory subunit B' (PR 53); PPP2R4 8 4 9 AK127055.1 ubiquitin specific peptidase 4 (proto-oncogene); USP4 8 4 10 NM_016356.2 doublecortin domain containing 2; DCDC2 8 4 11 NM_005338.4 huntingtin interacting protein 1; HIP1 8 4 12 NM_003863.2 dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit; DPM2 8 5 1 NM_003977.1 aryl hydrocarbon receptor interacting protein; AIP 8 5 2 NM_000431.1 mevalonate kinase (mevalonic aciduria); MVK 8 5 3 AY332722.1 Homo sapiens insulin-like growth factor 1 receptor (IGF1R) gene, complete cds;; 8 5 4 NM_005623.2 chemokine (C-C motif) ligand 8; CCL8 8 5 5 BC012104.1 purinergic receptor P2Y, G-protein coupled, 2; P2RY2 8 5 6 BC015497.1 TEA domain family member 4; TEAD4 8 5 7 BC035198.1 pyruvate kinase, muscle; PKM2 8 5 8 NM_021078.1 GCN5 general control of amino-acid synthesis 5-like 2 (yeast); GCN5L2 8 5 9 NM_003455.2 zinc finger protein 202; ZNF202 8 5 10 NM_005439.1 myeloid leukemia factor 2; MLF2 8 5 11 NM_004048.2 beta-2-microglobulin; B2M 8 5 12 BC014482.1 signal transducer and activator of transcription 3 (acute-phase response factor); STAT3 8 6 1 NM_002728.4 proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein); PRG2 8 6 2 BC106072.1 nucleolar protein 1, 120kDa; NOL1 8 6 3 AY358871.1 immunoglobulin superfamily containing leucine-rich repeat; ISLR 8 6 4 NM_006572.3 guanine nucleotide binding protein (G protein), alpha 13; GNA13 8 6 5 AY732486.1 serpin peptidase inhibitor, clade G (C1 inhibitor), member 1, (angioedema, hereditary); SERPING1 8 6 6 NM_001065.2 tumor necrosis factor receptor superfamily, member 1A; TNFRSF1A 8 6 7 AF498953.1 RAB27A, member RAS oncogene family; RAB27A 8 6 8 NM_005994.3 T-box 2; TBX2 8 6 9 CR624204.1 midkine (neurite growth-promoting factor 2); MDK 8 6 10 NM_003774.3 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4); GALNT4 8 6 11 NM_004663.3 RAB11A, member RAS oncogene family; RAB11A 8 6 12 NM_000419.3 integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B); ITGA2B 8 7 1 NM_005053.2 RAD23 homolog A (S. cerevisiae); RAD23A 8 7 2 NM_013396.3 ubiquitin specific peptidase 25; USP25 8 7 3 BC006190.2 PCTAIRE protein kinase 1; PCTK1 8 7 4 NM_000594.2 tumor necrosis factor (TNF superfamily, member 2); TNF 8 7 5 X97966.1 calcyphosine; CAPS 8 7 6 NM_006698.2 bladder cancer associated protein; BLCAP 8 7 7 NM_000074.2 CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome); CD40LG 8 7 8 BC000171.2 adenosylmethionine decarboxylase 1; AMD1 8 7 9 AC092143.4 Homo sapiens chromosome 16 clone RP11-566K11, complete sequence; ; 8 7 10 NM_006526.2 zinc finger protein 217; ZNF217 8 7 11 NM_001000.2 ribosomal protein L39; RPL39 8 7 12 BC112934.1 PR domain containing 10; PRDM10 8 8 1 BC018058.1 tumor necrosis factor (ligand) superfamily, member 14; TNFSF14 8 8 2 obsaracontrol#015 control oligonucleotide 8 8 3 NM_004251.3 RAB9A, member RAS oncogene family; RAB9A 8 8 4 NM_004598.3 sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1; SPOCK1 8 8 5 BC035385.1 kallikrein 12; KLK12 8 8 6 NM_002196.2 insulinoma-associated 1; INSM1 8 8 7 NM_016383.3 leucine zipper protein 4; LUZP4 8 8 8 BC015610.2 nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor); NR3C1 8 8 9 BC040887.1 kallikrein 8 (neuropsin/ovasin); KLK8 8 8 10 NM_000782.3 cytochrome P450, family 24, subfamily A, polypeptide 1; CYP24A1 8 8 11 J03069.1 v-myc myelocytomatosis viral oncogene homolog 2 (avian); MYCL2 8 8 12 NM_000679.3 adrenergic, alpha-1B-, receptor; ADRA1B 8 9 1 NM_002716.3 protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform; PPP2R1B 8 9 2 NM_021216.3 zinc finger protein 71 (Cos26); ZNF71 8 9 3 AJ001871.1 dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A; DYRK1A 8 9 4 NM_004332.1 biphenyl hydrolase-like (serine hydrolase; breast epithelial mucin-associated antigen); BPHL 8 9 5 NM_006292.2 tumor susceptibility gene 101; TSG101 8 9 6 NM_004720.4 endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 4; EDG4 8 9 7 BC006179.1 ribosomal protein L13; RPL13 8 9 8 CR602782.1 full-length cDNA clone CS0DB003YL08 of Neuroblastoma Cot 10-normalized of Homo sapiens (human);; 8 9 9 BC064357.1 phosphatidylinositol binding clathrin assembly protein; PICALM 8 9 10 NM_006532.2 elongation factor RNA polymerase II; ELL 8 9 11 NM_001655.3 archain 1; ARCN1 8 9 12 NM_002415.1 macrophage migration inhibitory factor (glycosylation-inhibiting factor); MIF 8 10 1 K00558 Alpha tubulin_2 8 10 2 NM_006905.2 pregnancy specific beta-1-glycoprotein 1; PSG1 8 10 3 NM_005309.1 glutamic-pyruvate transaminase (alanine aminotransferase); GPT 8 10 4 NM_005819.4 syntaxin 6; STX6 8 10 5 NM_021978.3 suppression of tumorigenicity 14 (colon carcinoma); ST14 8 10 6 U27325.1 thromboxane A2 receptor; TBXA2R 8 10 7 AK127449.1 wingless-type MMTV integration site family, member 2B; WNT2B 8 10 8 NM_002568.3 poly(A) binding protein, cytoplasmic 1; PABPC1 8 10 9 NM_002576.3 p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast); PAK1 8 10 10 NM_006149.2 lectin, galactoside-binding, soluble, 4 (galectin 4); LGALS4 8 10 11 BC009953.2 cell division cycle 25B; CDC25B 8 10 12 K00558 Alpha tubulin_2 9 1 1 L25899 Ribosomal protein L10 9 1 2 NM_012421.1 rearranged L-myc fusion; RLF 9 1 3 NM_003944.2 selenium binding protein 1; SELENBP1 9 1 4 NM_001766.2 CD1D antigen, d polypeptide; CD1D 9 1 5 NM_016373.1 WW domain containing oxidoreductase; WWOX 9 1 6 S78996.1 solute carrier family 19 (folate transporter), member 1; SLC19A1 9 1 7 BC011519.1 angiotensinogen (serpin peptidase inhibitor, clade A, member 8); AGT 9 1 8 NM_002036.2 Duffy blood group; FY 9 1 9 AF300328.1 melanoma antigen family D, 1; MAGED1 9 1 10 U13948.1 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10; MLLT10 9 1 11 NM_005872.2 breast carcinoma amplified sequence 2; BCAS2 9 1 12 obsaracontrol#014 control oligonucleotide 9 2 1 AF169796.1 RAD18 homolog (S. cerevisiae); RAD18 9 2 2 U02478.1 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4; MLLT4 9 2 3 NM_000983.3 ribosomal protein L22; RPL22 9 2 4 AY510272.1 glutathione S-transferase M1; GSTM1 9 2 5 NM_006665.3 heparanase; HPSE 9 2 6 NM_001729.1 betacellulin; BTC 9 2 7 NM_004736.2 xenotropic and polytropic retrovirus receptor; XPR1 9 2 8 NM_000849.3 glutathione S-transferase M3 (brain); GSTM3 9 2 9 NM_004655.2 axin 2 (conductin, axil); AXIN2 9 2 10 S52506.1 zinc finger protein 123 (HZF-1); ZNF123 9 2 11 BC021983.1 nucleophosmin (nucleolar phosphoprotein B23, numatrin); NPM1 9 2 12 NM_005092.2 tumor necrosis factor (ligand) superfamily, member 18; TNFSF18 9 3 1 AP000500.1 Homo sapiens genomic DNA, chromosome 3p21.3, clone:603 to 320, anti-oncogene region, section 3/3; ; 9 3 2 NM_003999.1 oncostatin M receptor; OSMR 9 3 3 AB019352.1 ras responsive element binding protein 1; RREB1 9 3 4 NM_001568.2 eukaryotic translation initiation factor 3, subunit 6 48kDa; EIF3S6 9 3 5 NM_005109.2 oxidative-stress responsive 1; OXSR1 9 3 6 NM_004932.2 cadherin 6, type 2, K-cadherin (fetal kidney); CDH6 9 3 7 NM_006290.2 tumor necrosis factor, alpha-induced protein 3; TNFAIP3 9 3 8 NM_003506.2 frizzled homolog 6 (Drosophila); FZD6 9 3 9 AP000497.1 Homo sapiens genomic DNA, chromosome 3p21.3, clone:301 to 308, anti-oncogene region, section 5/5; ; 9 3 10 NM_002198.1 interferon regulatory factor 1; IRF1 9 3 11 BC074721.2 hemochromatosis; HFE 9 3 12 NM_006167.2 NK3 transcription factor related, locus 1 (Drosophila); NKX3-1 9 4 1 NM_004733.2 solute carrier family 33 (acetyl-CoA transporter), member 1; SLC33A1 9 4 2 NM_017675.3 protocadherin LKC; PCLKC 9 4 3 NM_004568.4 serpin peptidase inhibitor, clade B (ovalbumin), member 6; SERPINB6 9 4 4 NM_004820.2 cytochrome P450, family 7, subfamily B, polypeptide 1; CYP7B1 9 4 5 AK125700.1 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2; PLOD2 9 4 6 NM_004827.2 ATP-binding cassette, sub-family G (WHITE), member 2; ABCG2 9 4 7 NM_003379.3 villin 2 (ezrin); VIL2 9 4 8 NM_005372.1 v-mos Moloney murine sarcoma viral oncogene homolog; MOS 9 4 9 NM_004635.3 mitogen-activated protein kinase-activated protein kinase 3; MAPKAPK3 9 4 10 BC106010.1 paired-like homeodomain transcription factor 2; PITX2 9 4 11 NM_000847.3 glutathione S-transferase A3; GSTA3 9 4 12 NM_012415.2 RAD54 homolog B (S. cerevisiae); RAD54B 9 5 1 NM_032727.2 internexin neuronal intermediate filament protein, alpha; INA 9 5 2 BC070083.1 plakophilin 2; PKP2 9 5 3 NM_006035.2 CDC42 binding protein kinase beta (DMPK-like); CDC42BPB 9 5 4 NM_003961.1 rhomboid, veinlet-like 1 (Drosophila); RHBDL1 9 5 5 NM_001613.1 actin, alpha 2, smooth muscle, aorta; ACTA2 9 5 6 NM_013377.2 PDZ domain containing RING finger 4; PDZRN4 9 5 7 CR609862.1 delta-like 1 homolog (Drosophila); DLK1 9 5 8 NM_005009.2 non-metastatic cells 4, protein expressed in; NME4 9 5 9 NM_000314.3 phosphatase and tensin homolog (mutated in multiple advanced cancers 1); PTEN 9 5 10 NM_003377.3 vascular endothelial growth factor B; VEGFB 9 5 11 NM_006668.1 cytochrome P450, family 46, subfamily A, polypeptide 1; CYP46A1 9 5 12 NM_001795.2 cadherin 5, type 2, VE-cadherin (vascular epithelium); CDH5 9 6 1 AF260262.1 abl-interactor 1; ABI1 9 6 2 NM_004579.2 mitogen-activated protein kinase kinase kinase kinase 2; MAP4K2 9 6 3 BC064355.1 CTAGE family, member 5; CTAGE5 9 6 4 NM_014353.4 RAB26, member RAS oncogene family; RAB26 9 6 5 NM_003380.2 vimentin; VIM 9 6 6 NM_006244.2 protein phosphatase 2, regulatory subunit B (B56), beta isoform; PPP2R5B 9 6 7 NM_000321.1 retinoblastoma 1 (including osteosarcoma); RB1 9 6 8 NM_001481.1 growth arrest-specific 8; GAS8 9 6 9 AY644456.1 chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1); CXCL12 9 6 10 NM_001997.3 Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived); ribosomal protein S30; FAU 9 6 11 NM_001922.2 dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2); DCT 9 6 12 NM_005611.2 retinoblastoma-like 2 (p130); RBL2 9 7 1 obsaracontrol#014 control oligonucleotide 9 7 2 NM_003425.2 zinc finger protein 45; ZNF45 9 7 3 AL117466.1 LIM domain kinase 2; LIMK2 9 7 4 BC017197.2 myeloid cell leukemia sequence 1 (BCL2-related); MCL1 9 7 5 NM_000546.2 tumor protein p53 (Li-Fraumeni syndrome); TP53 9 7 6 NM_003407.1 zinc finger protein 36, C3H type, homolog (mouse); ZFP36 9 7 7 NM_004861.1 galactose-3-O-sulfotransferase 1; GAL3ST1 9 7 8 BC012796.2 CDC42 small effector 1; CDC42SE1 9 7 9 NM_001067.2 topoisomerase (DNA) II alpha 170kDa; TOP2A 9 7 10 NM_003775.2 endothelial differentiation, G-protein-coupled receptor 6; EDG6 9 7 11 NM_002309.2 leukemia inhibitory factor (cholinergic differentiation factor); LIF 9 7 12 NM_005613.3 regulator of G-protein signalling 4; RGS4 9 8 1 BC036093.1 hepatic leukemia factor; HLF 9 8 2 NM_002446.2 mitogen-activated protein kinase kinase kinase 10; MAP3K10 9 8 3 NM_021076.2 neurofilament, heavy polypeptide 200kDa; NEFH 9 8 4 NM_003738.3 patched homolog 2 (Drosophila); PTCH2 9 8 5 NR_002219.1 effector cell peptidase receptor 1; EPR1 9 8 6 NM_014297.3 ethylmalonic encephalopathy 1; ETHE1 9 8 7 NM_002430.2 meningioma (disrupted in balanced translocation) 1; MN1 9 8 8 NM_001785.2 cytidine deaminase; CDA 9 8 9 BC041569.1 Homo sapiens forkhead box K2, mRNA (cDNA clone IMAGE:3531329), partial cds;; 9 8 10 NM_004364.2 CCAAT/enhancer binding protein (C/EBP), alpha; CEBPA 9 8 11 AK024025.1 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1; SMARCB1 9 8 12 AL731892.6 Human DNA sequence from clone RP11-346M5 on chromosome 1 Contains the 5' end of a cytochrome P450 4Z1 (CYP4Z1) pseudogene, a tubulin alpha pseudogene, the CYP4A11 gene for cytochrome P450 family 4 subfamily A polypeptide 11, complete sequence;; 9 9 1 NM_021631.1 apoptosis inhibitor; FKSG2 9 9 2 BC040109.1 A kinase (PRKA) anchor protein 13; AKAP13 9 9 3 NM_005215.1 deleted in colorectal carcinoma; DCC 9 9 4 NM_001379.1 DNA (cytosine-5-)-methyltransferase 1; DNMT1 9 9 5 NM_004874.2 BCL2-associated athanogene 4; BAG4 9 9 6 NM_004855.3 phosphatidylinositol glycan, class B; PIGB 9 9 7 BC072386.1 protein tyrosine phosphatase, receptor type, R; PTPRR 9 9 8 NM_020381.2 chromosome 6 open reading frame 210; C6orf210 9 9 9 NM_006283.1 transforming, acidic coiled-coil containing protein 1; TACC1 9 9 10 AL117259.6 Human chromosome 14 DNA sequence BAC R-304M6 of library RPCI-11 from chromosome 14 of Homo sapiens (Human), complete sequence;; 9 9 11 BC006462.1 SMT3 suppressor of mif two 3 homolog 1 (yeast); SUMO1 9 9 12 BC036498.1 matrin 3; MATR3 9 10 1 M26880 ubiquitin_2 9 10 2 NM_006029.4 paraneoplastic antigen MA1; PNMA1 9 10 3 NM_002206.1 integrin, alpha 7; ITGA7 9 10 4 NM_022963.2 fibroblast growth factor receptor 4; FGFR4 9 10 5 NM_003844.2 tumor necrosis factor receptor superfamily, member 10a; TNFRSF10A 9 10 6 NM_022118.3 chromosome 13 open reading frame 10; C13orf10 9 10 7 NM_001014.3 ribosomal protein S10; RPS10 9 10 8 NM_001946.2 dual specificity phosphatase 6; DUSP6 9 10 9 NM_000127.2 exostoses (multiple) 1; EXT1 9 10 10 BC039829.1 DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26; DDX26 9 10 11 AK131465.1 v-akt murine thymoma viral oncogene homolog 1; AKT1 9 10 12 NM_003226.2 trefoil factor 3 (intestinal); TFF3 10 1 1 X02592.1 T cell receptor alpha constant; TRAC 10 1 2 NM_002688.4 septin 5; SEPT5 10 1 3 NM_003036.1 v-ski sarcoma viral oncogene homolog (avian); SKI 10 1 4 NM_004735.2 leucine rich repeat (in FLII) interacting protein 1; LRRFIP1 10 1 5 NM_000267.1 neurofibromin 1 (neurofibromatosis, von Recklinghausen disease, Watson disease); NF1 10 1 6 NM_001381.2 docking protein 1, 62kDa (downstream of tyrosine kinase 1); DOK1 10 1 7 NM_004958.2 FK506 binding protein 12-rapamycin associated protein 1; FRAP1 10 1 8 BT006865.1 bridging integrator 1; BIN1 10 1 9 NM_021966.1 T-cell leukemia/lymphoma 1A; TCL1A 10 1 10 NM_006079.3 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2; CITED2 10 1 11 NM_002867.2 RAB3B, member RAS oncogene family; RAB3B 10 1 12 obsaracontrol#015 control oligonucleotide 10 2 1 BC002807.2 membrane-spanning 4-domains, subfamily A, member 1; MS4A1 10 2 2 NM_002655.1 pleiomorphic adenoma gene 1; PLAG1 10 2 3 NM_004582.2 Rab geranylgeranyltransferase, beta subunit; RABGGTB 10 2 4 NM_005383.1 sialidase 2 (cytosolic sialidase); NEU2 10 2 5 BC001901.2 BCL2-antagonist of cell death; BAD 10 2 6 NM_000392.1 ATP-binding cassette, sub-family C (CFTR/MRP), member 2; ABCC2 10 2 7 NM_001039664.1 tumor necrosis factor receptor superfamily, member 25; TNFRSF25 10 2 8 NM_000465.1 BRCA1 associated RING domain 1; BARD1 10 2 9 NM_153649.2 tropomyosin 3; TPM3 10 2 10 NM_002158.2 human T-cell leukemia virus enhancer factor; HTLF 10 2 11 NM_002228.3 v-jun sarcoma virus 17 oncogene homolog (avian); JUN 10 2 12 AY728138.1 chemokine (C-X-C motif) receptor 4; CXCR4 10 3 1 BC040499.1 transforming growth factor, beta receptor II (70/80kDa); TGFBR2 10 3 2 NM_000949.2 prolactin receptor; PRLR 10 3 3 AC073275.8 Homo sapiens BAC clone RP11-651K8 from 7, complete sequence; ; 10 3 4 NM_006648.3 WNK lysine deficient protein kinase 2; WNK2 10 3 5 AY501390.1 retinoic acid receptor, beta; RARB 10 3 6 NM_005654.4 nuclear receptor subfamily 2, group F, member 1; NR2F1 10 3 7 NM_004333.3 v-raf murine sarcoma viral oncogene homolog B1; BRAF 10 3 8 NM_001216.1 carbonic anhydrase IX; CA9 10 3 9 BC006811.1 peroxisome proliferative activated receptor, gamma; PPARG 10 3 10 NM_001343.1 disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila); DAB2 10 3 11 NM_006716.3 DBF4 homolog (S. cerevisiae); DBF4 10 3 12 NM_002732.2 protein kinase, cAMP-dependent, catalytic, gamma; PRKACG 10 4 1 NM_002899.2 retinol binding protein 1, cellular; RBP1 10 4 2 NM_002310.3 leukemia inhibitory factor receptor; LIFR 10 4 3 NM_012449.2 six transmembrane epithelial antigen of the prostate 1; STEAP1 10 4 4 BT007146.1 olfactomedin 1; OLFM1 10 4 5 NM_033049.2 mucin 13, epithelial transmembrane; MUC13 10 4 6 NM_006317.3 brain abundant, membrane attached signal protein 1; BASP1 10 4 7 NM_014452.3 tumor necrosis factor receptor superfamily, member 21; TNFRSF21 10 4 8 NM_001244.2 tumor necrosis factor (ligand) superfamily, member 8; TNFSF8 10 4 9 NM_007027.2 topoisomerase (DNA) II binding protein 1; TOPBP1 10 4 10 NM_201634.1 transcription factor 7 (T-cell specific, HMG-box); TCF7 10 4 11 NM_001264.3 corneodesmosin; CDSN 10 4 12 NM_001735.2 complement component 5; C5 10 5 1 NM_012250.3 related RAS viral (r-ras) oncogene homolog 2; RRAS2 10 5 2 NM_002223.1 inositol 1,4,5-triphosphate receptor, type 2; ITPR2 10 5 3 NM_005252.2 v-fos FBJ murine osteosarcoma viral oncogene homolog; FOS 10 5 4 NM_000250.1 myeloperoxidase; MPO 10 5 5 BC016660.1 heat shock 70kDa protein 8; HSPA8 10 5 6 NM_004642.2 CDK2-associated protein 1; CDK2AP1 10 5 7 NM_003239.1 transforming growth factor, beta 3; TGFB3 10 5 8 NM_005937.2 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6; MLLT6 10 5 9 NM_005188.2 Cas-Br-M (murine) ecotropic retroviral transforming sequence; CBL 10 5 10 BC003065.2 cyclin-dependent kinase 2; CDK2 10 5 11 NM_000369.2 thyroid stimulating hormone receptor; TSHR 10 5 12 NM_001988.1 envoplakin; EVPL 10 6 1 NM_006288.2 Thy-1 cell surface antigen; THY1 10 6 2 NM_001982.2 v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian); ERBB3 10 6 3 NM_005197.2 checkpoint suppressor 1; CHES1 10 6 4 NM_002720.1 protein phosphatase 4 (formerly X), catalytic subunit; PPP4C 10 6 5 NM_017716.1 membrane-spanning 4-domains, subfamily A, member 12; MS4A12 10 6 6 NM_005895.3 golgi autoantigen, golgin subfamily a, 3; GOLGA3 10 6 7 BC003003.1 reticulon 1; RTN1 10 6 8 NM_016292.1 TNF receptor-associated protein 1; TRAP1 10 6 9 NM_014207.2 CD5 antigen (p56-62); CD5 10 6 10 NM_004316.2 achaete-scute complex-like 1 (Drosophila); ASCL1 10 6 11 NM_006255.3 protein kinase C, eta; PRKCH 10 6 12 BC015623.2 major vault protein; MVP 10 7 1 NM_004163.3 RAB27B, member RAS oncogene family; RAB27B 10 7 2 obsaracontrol#015 control oligonucleotide 10 7 3 BC000809.1 transcription elongation factor A (SII)-like 1; TCEAL1 10 7 4 AF439430.1 thyroid peroxidase; TPO 10 7 5 NM_203291.1 retinoblastoma binding protein 8; RBBP8 10 7 6 AL121845.20 Human DNA sequence from clone RP4-583P15 on chromosome 20 Contains the 3' end of the TNFRSF6B gene for member 6 (decoy) of tumornecrosis factor receptor, the ARFRP1 gene for ADP-ribosylation ctor related protein 1, the gene for a novel protein (KIAA1847,F 10 7 7 NM_000169.1 galactosidase, alpha; GLA 10 7 8 NM_007315.2 signal transducer and activator of transcription 1, 91kDa; STAT1 10 7 9 BC008749.2 myelin basic protein; MBP 10 7 10 AC092309.3 Homo sapiens chromosome 19 clone LLNLR-276F4, complete sequence;; 10 7 11 NM_004988.3 melanoma antigen family A, 1 (directs expression of antigen MZ2-E); MAGEA1 10 7 12 NM_002398.2 Meis1, myeloid ecotropic viral integration site 1 homolog (mouse); MEIS1 10 8 1 NM_005359.3 SMAD, mothers against DPP homolog 4 (Drosophila); SMAD4 10 8 2 NM_003025.2 SH3-domain GRB2-like 1; SH3GL1 10 8 3 NM_007052.3 NADPH oxidase 1; NOX1 10 8 4 NM_003507.1 frizzled homolog 7 (Drosophila); FZD7 10 8 5 NM_001792.2 cadherin 2, type 1, N-cadherin (neuronal); CDH2 10 8 6 NM_003423.2 zinc finger protein 43 (HTF6); ZNF43 10 8 7 NM_000262.1 N-acetylgalactosaminidase, alpha-; NAGA 10 8 8 NM_002410.2 mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase; MGAT5 10 8 9 NM_006101.1 kinetochore associated 2; KNTC2 10 8 10 NM_001009.3 ribosomal protein S5; RPS5 10 8 11 NM_001429.2 E1A binding protein p300; EP300 10 8 12 NM_005400.2 protein kinase C, epsilon; PRKCE 10 9 1 NM_000773.3 cytochrome P450, family 2, subfamily E, polypeptide 1; CYP2E1 10 9 2 NM_005082.4 tripartite motif-containing 25; TRIM25 10 9 3 NM_002843.2 protein tyrosine phosphatase, receptor type, J; PTPRJ 10 9 4 NM_003212.1 teratocarcinoma-derived growth factor 1; TDGF1 10 9 5 DQ180742.1 prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase); PTGS1 10 9 6 NM_004035.5 acyl-Coenzyme A oxidase 1, palmitoyl; ACOX1 10 9 7 NM_012466.2 tetraspanin 16; TSPAN16 10 9 8 NM_006208.1 ectonucleotide pyrophosphatase/phosphodiesterase 1; ENPP1 10 9 9 NM_000118.1 endoglin (Osler-Rendu-Weber syndrome 1); ENG 10 9 10 BC003512.1 mesothelin; MSLN 10 9 11 NM_018557.2 low density lipoprotein-related protein 1B (deleted in tumors); LRP1B 10 9 12 CR749835.1 ATP-binding cassette, sub-family C (CFTR/MRP), member 1; ABCC1 10 10 1 X01677 glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA, complete cds; glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12), replicated spot 10 10 2 NM_002153.1 hydroxysteroid (17-beta) dehydrogenase 2; HSD17B2 10 10 3 NM_006305.2 acidic (leucine-rich) nuclear phosphoprotein 32 family, member A; ANP32A 10 10 4 NM_003251.2 thyroid hormone responsive (SPOT14 homolog, rat); THRSP 10 10 5 NM_005802.2 topoisomerase I binding, arginine/serine-rich; TOPORS 10 10 6 AC004682.1 Homo sapiens Chromosome 16 BAC clone CIT987SK-A-259H10, complete sequence;; 10 10 7 NM_004690.2 LATS, large tumor suppressor, homolog 1 (Drosophila); LATS1 10 10 8 NM_022097.1 hepatocellular carcinoma antigen gene 520; LOC63928 10 10 9 NM_021002.1 interferon, alpha 6; IFNA6 10 10 10 NM_003119.2 spastic paraplegia 7, paraplegin (pure and complicated autosomal recessive); SPG7 10 10 11 BC034689.1 UL16 binding protein 2; ULBP2 10 10 12 obsaracontrol#014 control oligonucleotide 11 1 1 M26880 ubiquitin_2 11 1 2 NM_004718.2 cytochrome c oxidase subunit VIIa polypeptide 2 like; COX7A2L 11 1 3 NM_004964.2 histone deacetylase 1; HDAC1 11 1 4 NM_001087.2 angio-associated, migratory cell protein; AAMP 11 1 5 M81339.1 thrombospondin 2; THBS2 11 1 6 NM_001262.2 cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4); CDKN2C 11 1 7 BC063482.1 tumor necrosis factor receptor superfamily, member 8; TNFRSF8 11 1 8 NM_000104.2 cytochrome P450, family 1, subfamily B, polypeptide 1; CYP1B1 11 1 9 L02424.1 Homo sapiens T-cell receptor alpha-chain mRNA, C region; ; 11 1 10 NM_020993.3 B-cell CLL/lymphoma 7A; BCL7A 11 1 11 NM_003292.1 translocated promoter region (to activated MET oncogene); TPR 11 1 12 CR601923.1 surfactant, pulmonary-associated protein B; SFTPB 11 2 1 J05158.2 carboxypeptidase N, polypeptide 2, 83kD; CPN2 11 2 2 NM_004504.3 HIV-1 Rev binding protein; HRB 11 2 3 NM_005465.3 v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma); AKT3 11 2 4 NM_003896.2 ST3 beta-galactoside alpha-2,3-sialyltransferase 5; ST3GAL5 11 2 5 NM_003018.2 surfactant, pulmonary-associated protein C; SFTPC 11 2 6 NM_002017.2 Friend leukemia virus integration 1; FLI1 11 2 7 NM_002353.1 tumor-associated calcium signal transducer 2; TACSTD2 11 2 8 CR613678.1 SP100 nuclear antigen; SP100 11 2 9 NM_001846.1 collagen, type IV, alpha 2; COL4A2 11 2 10 NM_001731.1 B-cell translocation gene 1, anti-proliferative; BTG1 11 2 11 NM_006618.3 Jumonji, AT rich interactive domain 1B (RBP2-like); JARID1B 11 2 12 AF015451.1 CASP8 and FADD-like apoptosis regulator; CFLAR 11 3 1 NM_007022.3 cytochrome b-561 domain containing 2; CYB561D2 11 3 2 AF057300.1 RAD50 homolog (S. cerevisiae); RAD50 11 3 3 NM_005402.2 v-ral simian leukemia viral oncogene homolog A (ras related); RALA 11 3 4 NM_000136.2 Fanconi anemia, complementation group C; FANCC 11 3 5 NM_007275.1 tumor suppressor candidate 2; TUSC2 11 3 6 BC067515.1 interleukin 4; IL4 11 3 7 NM_004956.3 ets variant gene 1; ETV1 11 3 8 NM_000197.1 hydroxysteroid (17-beta) dehydrogenase 3; HSD17B3 11 3 9 BC025774.1 hyaluronoglucosaminidase 1; HYAL1 11 3 10 NM_012081.3 elongation factor, RNA polymerase II, 2; ELL2 11 3 11 NM_013439.2 paired immunoglobin-like type 2 receptor alpha; PILRA 11 3 12 NM_002771.2 protease, serine, 3 (mesotrypsin); PRSS3 11 4 1 NM_006764.3 interferon-related developmental regulator 2; IFRD2 11 4 2 NM_000024.3 adrenergic, beta-2-, receptor, surface; ADRB2 11 4 3 BC010858.2 enhancer of zeste homolog 2 (Drosophila); EZH2 11 4 4 NM_005511.1 melan-A; MLANA 11 4 5 NM_004186.2 sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F; SEMA3F 11 4 6 NM_004661.2 CDC23 (cell division cycle 23, yeast, homolog); CDC23 11 4 7 BC051375.1 nudix (nucleoside diphosphate linked moiety X)-type motif 1; NUDT1 11 4 8 NM_005476.3 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase; GNE 11 4 9 CR749415.1 natural killer-tumor recognition sequence; NKTR 11 4 10 NM_016348.1 chromosome 5 open reading frame 4; C5orf4 11 4 11 NM_018487.2 hepatocellular carcinoma-associated antigen 112; HCA112 11 4 12 AF410899.1 neurotrophic tyrosine kinase, receptor, type 2; NTRK2 11 5 1 NM_002424.1 matrix metallopeptidase 8 (neutrophil collagenase); MMP8 11 5 2 NM_003979.3 G protein-coupled receptor, family C, group 5, member A; GPRC5A 11 5 3 NM_001150.1 alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13, p150); ANPEP 11 5 4 NM_004090.2 dual specificity phosphatase 3 (vaccinia virus phosphatase VH1-related); DUSP3 11 5 5 NM_002425.1 matrix metallopeptidase 10 (stromelysin 2); MMP10 11 5 6 AJ243107.1 apoptotic peptidase activating factor; APAF1 11 5 7 BC022069.1 cellular retinoic acid binding protein 1; CRABP1 11 5 8 NM_000697.1 arachidonate 12-lipoxygenase; ALOX12 11 5 9 NM_007037.3 ADAM metallopeptidase with thrombospondin type 1 motif, 8; ADAMTS8 11 5 10 NM_020525.4 interleukin 22; IL22 11 5 11 NM_014272.2 ADAM metallopeptidase with thrombospondin type 1 motif, 7; ADAMTS7 11 5 12 NM_013975.2 ligase III, DNA, ATP-dependent; LIG3 11 6 1 obsaracontrol#015 control oligonucleotide 11 6 2 AC008119.6 Homo sapiens 12 BAC RP11-951I11 (Roswell Park Cancer Institute Human BAC Library) complete sequence;; 11 6 3 BC018702.1 serine peptidase inhibitor, Kunitz type 1; SPINT1 11 6 4 NM_012329.2 monocyte to macrophage differentiation-associated; MMD 11 6 5 BC029743.1 E74-like factor 5 (ets domain transcription factor); ELF5 11 6 6 BC016147.1 nuclear receptor subfamily 4, group A, member 1; NR4A1 11 6 7 NM_002220.1 inositol 1,4,5-trisphosphate 3-kinase A; ITPKA 11 6 8 NM_000873.2 intercellular adhesion molecule 2; ICAM2 11 6 9 NM_006410.3 HIV-1 Tat interactive protein 2, 30kDa; HTATIP2 11 6 10 NM_000020.1 activin A receptor type II-like 1; ACVRL1 11 6 11 BC030589.2 aldehyde dehydrogenase 1 family, member A2; ALDH1A2 11 6 12 BC033245.1 colony stimulating factor 3 (granulocyte); CSF3 11 7 1 NM_012427.3 kallikrein 5; KLK5 11 7 2 BC042168.1 cathepsin Z; CTSZ 11 7 3 CR541762.1 melanoma antigen family B, 1; MAGEB1 11 7 4 S69965.1 synuclein, beta; SNCB 11 7 5 NM_004851.1 napsin A aspartic peptidase; NAPSA 11 7 6 BC000491.2 proliferating cell nuclear antigen; PCNA 11 7 7 NM_002024.3 fragile X mental retardation 1; FMR1 11 7 8 NM_001334.2 cathepsin O; CTSO 11 7 9 NM_001013.3 ribosomal protein S9; RPS9 11 7 10 BC027464.1 serine/threonine kinase 6; STK6 11 7 11 NM_005369.2 MCF.2 cell line derived transforming sequence; MCF2 11 7 12 AY597415.1 ribosomal protein L9; RPL9 11 8 1 NM_005370.4 RAB8A, member RAS oncogene family; RAB8A 11 8 2 NM_002110.2 hemopoietic cell kinase; HCK 11 8 3 AL832514.1 kelch-like 4 (Drosophila); KLHL4 11 8 4 AK075463.1 secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early T-lymphocyte activation 1); SPP1 11 8 5 NM_000660.3 transforming growth factor, beta 1 (Camurati-Engelmann disease); TGFB1 11 8 6 BC046106.1 WAP four-disulfide core domain 2; WFDC2 11 8 7 BC025298.1 interleukin 9 receptor; IL9R 11 8 8 AC021205.6 Homo sapiens BAC clone RP11-170N16 from 4, complete sequence;; 11 8 9 NM_000991.3 ribosomal protein L28; RPL28 11 8 10 NM_003881.2 WNT1 inducible signaling pathway protein 2; WISP2 11 8 11 NM_012317.2 leucine zipper, down-regulated in cancer 1; LDOC1 11 8 12 NM_002447.1 macrophage stimulating 1 receptor (c-met-related tyrosine kinase); MST1R 11 9 1 BC032861.2 Wilms tumor 1; WT1 11 9 2 NM_005628.1 solute carrier family 1 (neutral amino acid transporter), member 5; SLC1A5 11 9 3 BC029378.1 telomeric repeat binding factor (NIMA-interacting) 1; TERF1 11 9 4 NG_002574.1 ribosomal protein S8 pseudogene 1; RPS8P1 11 9 5 NM_005146.3 squamous cell carcinoma antigen recognised by T cells; SART1 11 9 6 NM_004363.1 carcinoembryonic antigen-related cell adhesion molecule 5; CEACAM5 11 9 7 NM_006761.3 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide; YWHAE 11 9 8 NM_012222.1 mutY homolog (E. coli); MUTYH 11 9 9 NM_005898.4 GPI-anchored membrane protein 1; GPIAP1 11 9 10 NM_005428.2 vav 1 oncogene; VAV1 11 9 11 AC053481.13 Homo sapiens chromosome 17, clone RP11-51L5, complete sequence;; 11 9 12 NM_020979.1 adaptor protein with pleckstrin homology and src homology 2 domains; APS 11 10 1 BC008771.2 MAP/microtubule affinity-regulating kinase 2; MARK2 11 10 2 AK122765.1 transcription factor 4; TCF4 11 10 3 NM_002128.3 high-mobility group box 1; HMGB1 11 10 4 NM_005603.2 ATPase, Class I, type 8B, member 1; ATP8B1 11 10 5 NM_002977.1 sodium channel, voltage-gated, type IX, alpha; SCN9A 11 10 6 NM_024430.2 proline-serine-threonine phosphatase interacting protein 2; PSTPIP2 11 10 7 NM_001417.3 eukaryotic translation initiation factor 4B; EIF4B 11 10 8 NM_006284.2 TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa; TAF10 11 10 9 NM_006562.4 ladybird homeobox homolog 1 (Drosophila); LBX1 11 10 10 NM_003787.1 nucleolar protein 4; NOL4 11 10 11 NG_000008.6 Homo sapiens cytochrome P450, family 2, subfamily A (CYP2A) on chromosome 19;; 11 10 12 L25899 Ribosomal protein L10 12 1 1 L25899 Ribosomal protein L10 12 1 2 NM_002387.1 mutated in colorectal cancers; MCC 12 1 3 BC010032.2 LAG1 longevity assurance homolog 2 (S. cerevisiae); LASS2 12 1 4 NM_004688.1 N-myc (and STAT) interactor; NMI 12 1 5 NM_000404.1 galactosidase, beta 1; GLB1 12 1 6 NM_005263.2 growth factor independent 1; GFI1 12 1 7 NM_014747.2 regulating synaptic membrane exocytosis 3; RIMS3 12 1 8 NM_001692.3 ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B, isoform 1 (Renal tubular acidosis with deafness); ATP6V1B1 12 1 9 Z68228.1 junction plakoglobin; JUP 12 1 10 NM_004794.2 RAB33A, member RAS oncogene family; RAB33A 12 1 11 NM_003431.2 zinc finger protein 124 (HZF-16); ZNF124 12 1 12 L25899 Ribosomal protein L10 12 2 1 NM_005232.3 EPH receptor A1; EPHA1 12 2 2 NM_138578.1 BCL2-like 1; BCL2L1 12 2 3 NM_007123.4 Usher syndrome 2A (autosomal recessive, mild); USH2A 12 2 4 NM_000179.1 mutS homolog 6 (E. coli); MSH6 12 2 5 NM_002350.1 v-yes-1 Yamaguchi sarcoma viral related oncogene homolog; LYN 12 2 6 NM_004708.2 programmed cell death 5; PDCD5 12 2 7 NM_020526.3 EPH receptor A8; EPHA8 12 2 8 NM_004161.3 RAB1A, member RAS oncogene family; RAB1A 12 2 9 NM_000075.2 cyclin-dependent kinase 4; CDK4 12 2 10 NM_021127.1 phorbol-12-myristate-13-acetate-induced protein 1; PMAIP1 12 2 11 NM_012134.1 leiomodin 1 (smooth muscle); LMOD1 12 2 12 NM_012413.3 glutaminyl-peptide cyclotransferase (glutaminyl cyclase); QPCT 12 3 1 NM_002448.2 msh homeo box homolog 1 (Drosophila); MSX1 12 3 2 BC069192.1 Wilms tumor 1 associated protein; WTAP 12 3 3 BC007231.1 plasminogen activator, tissue; PLAT 12 3 4 NM_000242.1 mannose-binding lectin (protein C) 2, soluble (opsonic defect); MBL2 12 3 5 AF245114.1 fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism); FGFR3 12 3 6 NM_000876.1 insulin-like growth factor 2 receptor; IGF2R 12 3 7 AY750146.1 acetylcholinesterase (YT blood group); ACHE 12 3 8 NM_000417.1 interleukin 2 receptor, alpha; IL2RA 12 3 9 BC039610.1 protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase); PTPN13 12 3 10 NM_019111.3 major histocompatibility complex, class II, DR alpha; HLA-DRA 12 3 11 NM_003227.2 transferrin receptor 2; TFR2 12 3 12 NM_000429.2 methionine adenosyltransferase I, alpha; MAT1A 12 4 1 NM_000938.1 polymerase (RNA) II (DNA directed) polypeptide B, 140kDa; POLR2B 12 4 2 NM_002586.3 pre-B-cell leukemia transcription factor 2; PBX2 12 4 3 NM_002360.3 v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian); MAFK 12 4 4 NM_005180.5 polycomb group ring finger 4; PCGF4 12 4 5 NM_005506.2 scavenger receptor class B, member 2; SCARB2 12 4 6 NM_000500.5 cytochrome P450, family 21, subfamily A, polypeptide 2; CYP21A2 12 4 7 NM_001259.5 cyclin-dependent kinase 6; CDK6 12 4 8 NM_000700.1 annexin A1; ANXA1 12 4 9 NM_003023.2 SH3-domain binding protein 2; SH3BP2 12 4 10 AF134726.1 Homo sapiens BAC clone 215O12 NG35, NG36, G9A, NG22, G9, HSP70-2, HSP70-1, HSP70-HOM, snRNP, G7A, NG37, NG23, and MutSH5 genes, complete cds;; 12 4 11 NM_000492.3 cystic fibrosis transmembrane conductance regulator, ATP-binding cassette (sub-family C, member 7); CFTR 12 4 12 L27211.1 cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); CDKN2A 12 5 1 NM_001467.3 solute carrier family 37 (glycerol-6-phosphate transporter), member 4; SLC37A4 12 5 2 NM_001260.1 cyclin-dependent kinase 8; CDK8 12 5 3 NM_000761.3 cytochrome P450, family 1, subfamily A, polypeptide 2; CYP1A2 12 5 4 NM_000638.3 vitronectin (serum spreading factor, somatomedin B, complement S-protein); VTN 12 5 5 BT019649.1 transgelin; TAGLN 12 5 6 NM_006573.3 tumor necrosis factor (ligand) superfamily, member 13b; TNFSF13B 12 5 7 NM_000137.1 fumarylacetoacetate hydrolase (fumarylacetoacetase); FAH 12 5 8 NM_005208.3 crystallin, beta A1; CRYBA1 12 5 9 NM_002411.1 secretoglobin, family 2A, member 2; SCGB2A2 12 5 10 BC033465.1 vitamin D (1,25- dihydroxyvitamin D3) receptor; VDR 12 5 11 NM_001135.1 aggrecan 1 (chondroitin sulfate proteoglycan 1, large aggregating proteoglycan, antigen identified by monoclonal antibody A0122); AGC1 12 5 12 BC035572.1 ecotropic viral integration site 2A; EVI2A 12 6 1 NM_003282.2 troponin I type 2 (skeletal, fast); TNNI2 12 6 2 obsaracontrol#014 control oligonucleotide 12 6 3 NM_006011.3 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2; ST8SIA2 12 6 4 NM_002984.2 chemokine (C-C motif) ligand 4; CCL4 12 6 5 BC001888.1 protein phosphatase 1, catalytic subunit, alpha isoform; PPP1CA 12 6 6 NM_002859.1 paxillin; PXN 12 6 7 NM_002487.2 necdin homolog (mouse); NDN 12 6 8 NM_002507.1 nerve growth factor receptor (TNFR superfamily, member 16); NGFR 12 6 9 NM_005851.3 CDK2-associated protein 2; CDK2AP2 12 6 10 AF526277.1 uracil-DNA glycosylase; UNG 12 6 11 BC070339.1 dUTP pyrophosphatase; DUT 12 6 12 NM_003786.2 ATP-binding cassette, sub-family C (CFTR/MRP), member 3; ABCC3 12 7 1 NM_004324.3 BCL2-associated X protein; BAX 12 7 2 NM_005423.3 trefoil factor 2 (spasmolytic protein 1); TFF2 12 7 3 NM_004681.2 eukaryotic translation initiation factor 1A, Y-linked; EIF1AY 12 7 4 NM_017460.3 cytochrome P450, family 3, subfamily A, polypeptide 4; CYP3A4 12 7 5 BC013586.1 protein kinase C substrate 80K-H; PRKCSH 12 7 6 AY372061.1 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5; B3GALT5 12 7 7 NM_018684.1 KIAA1166; KIAA1166 12 7 8 BC034040.1 protein tyrosine phosphatase, receptor type, N polypeptide 2; PTPRN2 12 7 9 NM_003072.2 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4; SMARCA4 12 7 10 NM_001757.2 carbonyl reductase 1; CBR1 12 7 11 L29496.1 androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease); AR 12 7 12 NM_004155.3 serpin peptidase inhibitor, clade B (ovalbumin), member 9; SERPINB9 12 8 1 NM_004317.2 arsA arsenite transporter, ATP-binding, homolog 1 (bacterial); ASNA1 12 8 2 NM_000454.4 superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)); SOD1 12 8 3 NM_000640.2 interleukin 13 receptor, alpha 2; IL13RA2 12 8 4 BC050726.2 cyclin C; CCNC 12 8 5 DQ231563.1 peroxiredoxin 2; PRDX2 12 8 6 NM_020152.2 chromosome 21 open reading frame 7; C21orf7 12 8 7 NM_001654.1 v-raf murine sarcoma 3611 viral oncogene homolog; ARAF 12 8 8 NM_021922.2 Fanconi anemia, complementation group E; FANCE 12 8 9 NM_004461.1 phenylalanine-tRNA synthetase-like, alpha subunit; FARSLA 12 8 10 BC065523.1 amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease); APP 12 8 11 NM_002025.2 AF4/FMR2 family, member 2; AFF2 12 8 12 AY375949.1 major histocompatibility complex, class II, DQ alpha 1; HLA-DQA1 12 9 1 NM_012306.2 Fas apoptotic inhibitory molecule 2; FAIM2 12 9 2 BC106758.1 cytochrome P450, family 2, subfamily D, polypeptide 6; CYP2D6 12 9 3 NM_000415.1 islet amyloid polypeptide; IAPP 12 9 4 BX649185.1 B-cell CLL/lymphoma 6 (zinc finger protein 51); BCL6 12 9 5 NM_002178.2 insulin-like growth factor binding protein 6; IGFBP6 12 9 6 NM_004339.2 pituitary tumor-transforming 1 interacting protein; PTTG1IP 12 9 7 NM_003394.2 wingless-type MMTV integration site family, member 10B; WNT10B 12 9 8 NM_003372.4 von Hippel-Lindau binding protein 1; VBP1 12 9 9 NM_001759.2 cyclin D2; CCND2 12 9 10 NM_021081.3 growth hormone releasing hormone; GHRH 12 9 11 NM_005516.4 major histocompatibility complex, class I, E; HLA-E 12 9 12 NM_014264.2 polo-like kinase 4 (Drosophila); PLK4 12 10 1 NM_001644.3 apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1; APOBEC1 12 10 2 NM_001719.1 bone morphogenetic protein 7 (osteogenic protein 1); BMP7 12 10 3 NM_006218.2 phosphoinositide-3-kinase, catalytic, alpha polypeptide; PIK3CA 12 10 4 AY775289.1 HMT1 hnRNP methyltransferase-like 2 (S. cerevisiae); HRMT1L2 12 10 5 NM_006268.3 D4, zinc and double PHD fingers family 2; DPF2 12 10 6 NM_003286.2 topoisomerase (DNA) I; TOP1 12 10 7 BC026033.1 gelsolin (amyloidosis, Finnish type); GSN 12 10 8 NM_005270.3 GLI-Kruppel family member GLI2; GLI2 12 10 9 NM_014555.2 transient receptor potential cation channel, subfamily M, member 5; TRPM5 12 10 10 NM_000455.4 serine/threonine kinase 11; STK11 12 10 11 NM_004232.2 suppressor of cytokine signaling 6; SOCS6 12 10 12 M26880 ubiquitin_2 13 1 1 X63432 beta-actin, replicated spot 13 1 2 NM_004083.4 DNA-damage-inducible transcript 3; DDIT3 13 1 3 NM_001016.3 ribosomal protein S12; RPS12 13 1 4 NM_006142.3 stratifin; SFN 13 1 5 NM_007218.3 ring finger protein 139; RNF139 13 1 6 NM_014220.2 transmembrane 4 L six family member 1; TM4SF1 13 1 7 NM_001803.2 CD52 antigen (CAMPATH-1 antigen); CD52 13 1 8 BC107736.1 peptidylprolyl isomerase E (cyclophilin E); PPIE 13 1 9 AF039564.1 Homo sapiens retinoblastoma binding protein (RBBP9) mRNA, complete cds; 13 1 10 NM_005521.2 T-cell leukemia, homeobox 1; TLX1 13 1 11 NM_001018.3 ribosomal protein S15; RPS15 13 1 12 obsaracontrol#015 control oligonucleotide 13 2 1 obsaracontrol#015 control oligonucleotide 13 2 2 NM_003189.1 T-cell acute lymphocytic leukemia 1; TAL1 13 2 3 NM_000987.3 ribosomal protein L26; RPL26 13 2 4 NM_003921.2 B-cell CLL/lymphoma 10; BCL10 13 2 5 NM_001032999.2 core-binding factor, runt domain, alpha subunit 2; translocated to, 2; CBFA2T2 13 2 6 M61170.2 mucin 1, transmembrane; MUC1 13 2 7 NM_005118.2 tumor necrosis factor (ligand) superfamily, member 15; TNFSF15 13 2 8 NM_005373.1 myeloproliferative leukemia virus oncogene; MPL 13 2 9 NM_001702.1 brain-specific angiogenesis inhibitor 1; BAI1 13 2 10 X16323.1 hepatocyte growth factor (hepapoietin A; scatter factor); HGF 13 2 11 NM_021635.2 prostate and breast cancer overexpressed 1; PBOV1 13 2 12 NM_006516.1 solute carrier family 2 (facilitated glucose transporter), member 1; SLC2A1 13 3 1 NM_004423.3 dishevelled, dsh homolog 3 (Drosophila); DVL3 13 3 2 NM_004249.1 RAB28, member RAS oncogene family; RAB28 13 3 3 BC015789.1 high mobility group AT-hook 1; HMGA1 13 3 4 NM_003923.1 forkhead box H1; FOXH1 13 3 5 S76771.1 thrombopoietin (myeloproliferative leukemia virus oncogene ligand, megakaryocyte growth and development factor); THPO 13 3 6 NM_006798.1 UDP glucuronosyltransferase 2 family, polypeptide A1; UGT2A1 13 3 7 NM_016135.2 ets variant gene 7 (TEL2 oncogene); ETV7 13 3 8 AL359737.16 Human DNA sequence from clone RP11-484H12 on chromosome 13 Contains the 3' end of a novel gene, a novel pseudogene, two novel genes, a feminization 1 homolog a (FEM1A) (KIAA1785) pseudogene, a telomeric repeat binding factor (NIMA-interacting) 1 (TERF1) (TRF PIN2 TRF1 TRBF1 hTRF1-AS) pseudogene, a chromosome 21 open reading frame 70 (C21orf70) pseudogene and four CpG islands, complete sequence; 13 3 9 NM_003241.1 transglutaminase 4 (prostate); TGM4 13 3 10 NM_015393.2 DKFZP564O0823 protein; DKFZP564O0823 13 3 11 NM_001563.2 interphotoreceptor matrix proteoglycan 1; IMPG1 13 3 12 AC009314.4 Homo sapiens BAC clone RP11-465K4 from 8, complete sequence;; 13 4 1 NM_016577.2 RAB6B, member RAS oncogene family; RAB6B 13 4 2 NM_001657.2 amphiregulin (schwannoma-derived growth factor); AREG 13 4 3 NM_002944.2 v-ros UR2 sarcoma virus oncogene homolog 1 (avian); ROS1 13 4 4 NM_016240.2 scavenger receptor class A, member 3; SCARA3 13 4 5 NM_000888.3 integrin, beta 6; ITGB6 13 4 6 NM_002994.3 chemokine (C-X-C motif) ligand 5; CXCL5 13 4 7 NM_006238.3 peroxisome proliferative activated receptor, delta; PPARD 13 4 8 NM_002066.1 GPI anchored molecule like protein; GML 13 4 9 Z22641.1 chimerin (chimaerin) 1; CHN1 13 4 10 AB006757.1 BH-protocadherin (brain-heart); PCDH7 13 4 11 NM_005375.2 v-myb myeloblastosis viral oncogene homolog (avian); MYB 13 4 12 NM_007029.2 stathmin-like 2; STMN2 13 5 1 NM_003591.2 cullin 2; CUL2 13 5 2 NM_005438.2 FOS-like antigen 1; FOSL1 13 5 3 AY764035.1 ret finger protein 2; RFP2 13 5 4 NM_005652.2 telomeric repeat binding factor 2; TERF2 13 5 5 BC004977.1 interferon-induced protein with tetratricopeptide repeats 3; IFIT3 13 5 6 NM_001532.2 solute carrier family 29 (nucleoside transporters), member 2; SLC29A2 13 5 7 NM_002015.2 forkhead box O1A (rhabdomyosarcoma); FOXO1A 13 5 8 NM_014567.2 breast cancer anti-estrogen resistance 1; BCAR1 13 5 9 NM_012342.2 BMP and activin membrane-bound inhibitor homolog (Xenopus laevis); BAMBI 13 5 10 BC015571.2 solute carrier family 22 (organic cation transporter), member 18; SLC22A18 13 5 11 NM_014363.3 spastic ataxia of Charlevoix-Saguenay (sacsin); SACS 13 5 12 NM_001192.2 tumor necrosis factor receptor superfamily, member 17; TNFRSF17 13 6 1 NM_002412.2 O-6-methylguanine-DNA methyltransferase; MGMT 13 6 2 NM_005706.2 tumor suppressing subtransferable candidate 4; TSSC4 13 6 3 NM_015032.1 androgen-induced proliferation inhibitor; APRIN 13 6 4 NM_005236.1 excision repair cross-complementing rodent repair deficiency, complementation group 4; ERCC4 13 6 5 U32515.1 MAX interactor 1; MXI1 13 6 6 BC016693.1 tetraspanin 32; TSPAN32 13 6 7 NM_003045.3 solute carrier family 7 (cationic amino acid transporter, y+ system), member 1; SLC7A1 13 6 8 NM_017668.1 nudE nuclear distribution gene E homolog 1 (A. nidulans); NDE1 13 6 9 BC014563.1 cell division cycle 2, G1 to S and G2 to M; CDC2 13 6 10 BT006802.1 dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase); DPAGT1 13 6 11 NM_000123.2 excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome)); ERCC5 13 6 12 NM_000259.1 myosin VA (heavy polypeptide 12, myoxin); MYO5A 13 7 1 BC080193.1 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian); ERBB2 13 7 2 NM_006890.1 carcinoembryonic antigen-related cell adhesion molecule 7; CEACAM7 13 7 3 NM_004914.2 RAB36, member RAS oncogene family; RAB36 13 7 4 NM_012387.1 peptidyl arginine deiminase, type IV; PADI4 13 7 5 BC019608.1 vesicle-associated membrane protein 2 (synaptobrevin 2); VAMP2 13 7 6 NM_005317.2 granzyme M (lymphocyte met-ase 1); GZMM 13 7 7 NM_007128.2 pre-B lymphocyte gene 1; VPREB1 13 7 8 NM_002167.2 inhibitor of DNA binding 3, dominant negative helix-loop-helix protein; ID3 13 7 9 NM_000458.1 transcription factor 2, hepatic; LF-B3; variant hepatic nuclear factor; TCF2 13 7 10 NM_002307.1 lectin, galactoside-binding, soluble, 7 (galectin 7); LGALS7 13 7 11 Z11695.1 mitogen-activated protein kinase 1; MAPK1 13 7 12 BC010450.1 papillary renal cell carcinoma (translocation-associated); PRCC 13 8 1 NM_006612.3 kinesin family member 1C; KIF1C 13 8 2 NM_000164.2 gastric inhibitory polypeptide receptor; GIPR 13 8 3 NM_000185.3 serpin peptidase inhibitor, clade D (heparin cofactor), member 1; SERPIND1 13 8 4 NM_003327.2 tumor necrosis factor receptor superfamily, member 4; TNFRSF4 13 8 5 NM_002558.2 purinergic receptor P2X, ligand-gated ion channel, 1; P2RX1 13 8 6 NM_015711.1 glioma tumor suppressor candidate region gene 1; GLTSCR1 13 8 7 BC000727.2 HMT1 hnRNP methyltransferase-like 1 (S. cerevisiae); HRMT1L1 13 8 8 NM_006113.3 vav 3 oncogene; VAV3 13 8 9 NM_006224.2 phosphatidylinositol transfer protein, alpha; PITPNA 13 8 10 NM_000234.1 ligase I, DNA, ATP-dependent; LIG1 13 8 11 NM_000071.1 cystathionine-beta-synthase; CBS 13 8 12 NM_000110.2 dihydropyrimidine dehydrogenase; DPYD 13 9 1 obsaracontrol#014 control oligonucleotide 13 9 2 NM_004119.1 fms-related tyrosine kinase 3; FLT3 13 9 3 NM_020994.2 cancer/testis antigen 2; CTAG2 13 9 4 NM_002613.3 3-phosphoinositide dependent protein kinase-1; PDPK1 13 9 5 NM_000553.2 Werner syndrome; WRN 13 9 6 BC021219.2 dachshund homolog 1 (Drosophila); DACH1 13 9 7 NM_001363.2 dyskeratosis congenita 1, dyskerin; DKC1 13 9 8 BC074993.2 paired related homeobox 1; PRRX1 13 9 9 NM_004318.2 aspartate beta-hydroxylase; ASPH 13 9 10 NM_006260.2 DnaJ (Hsp40) homolog, subfamily C, member 3; DNAJC3 13 9 11 NM_021998.3 zinc finger protein 6 (CMPX1); ZNF6 13 9 12 NM_002467.3 v-myc myelocytomatosis viral oncogene homolog (avian); MYC 13 10 1 K00558 Alpha tubulin_2 13 10 2 AC009245.11 Homo sapiens chromosome 7 clone RP11-351B12, complete sequence;; 13 10 3 NM_000531.3 ornithine carbamoyltransferase; OTC 13 10 4 AL451126.18 Human DNA sequence from clone RP11-106G15 on chromosome 6 Contains the 5' end of a gene for a novel protein similar to arginyl-tRNA synthetase (arginine-tRNA ligase, EC 6.1.1.19) and the 5' end of the ORC3L gene for origin recognition complex, subunit 3-like (yeast), complete sequence; 13 10 5 NM_006749.3 solute carrier family 20 (phosphate transporter), member 2; SLC20A2 13 10 6 NM_003034.2 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1; ST8SIA1 13 10 7 NM_001666.2 Rho GTPase activating protein 4; ARHGAP4 13 10 8 NM_000593.5 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP); TAP1 13 10 9 X58430.1 homeo box A10; HOXA10 13 10 10 NM_018656.2 solute carrier family 35, member E3; SLC35E3 13 10 11 NM_005362.3 melanoma antigen family A, 3; MAGEA3 13 10 12 M26880 ubiquitin_2 14 1 1 BC093031.1 tetraspanin 4; TSPAN4 14 1 2 NM_004380.1 CREB binding protein (Rubinstein-Taybi syndrome); CREBBP 14 1 3 Z35141.1 paired box gene 7; PAX7 14 1 4 NM_002166.4 inhibitor of DNA binding 2, dominant negative helix-loop-helix protein; ID2 14 1 5 NM_003472.2 DEK oncogene (DNA binding); DEK 14 1 6 NM_001321.1 cysteine and glycine-rich protein 2; CSRP2 14 1 7 BT019423.1 neuroblastoma, suppression of tumorigenicity 1; NBL1 14 1 8 NM_016131.2 RAB10, member RAS oncogene family; RAB10 14 1 9 NM_032043.1 BRCA1 interacting protein C-terminal helicase 1; BRIP1 14 1 10 BC035498.2 cyclin E1; CCNE1 14 1 11 NM_004905.2 peroxiredoxin 6; PRDX6 14 1 12 AC007537.3 Homo sapiens 12 BAC RPCI11-267J23 (Roswell Park Cancer Institute Human BAC Library) complete sequence;; 14 2 1 U19601.1 runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene); RUNX1 14 2 2 obsaracontrol#014 control oligonucleotide 14 2 3 NM_175744.3 ras homolog gene family, member C; RHOC 14 2 4 M65085.1 follicle stimulating hormone receptor; FSHR 14 2 5 NM_182920.1 ADAM metallopeptidase with thrombospondin type 1 motif, 9; ADAMTS9 14 2 6 NM_004689.2 metastasis associated 1; MTA1 14 2 7 NM_000969.3 ribosomal protein L5; RPL5 14 2 8 NM_004460.2 fibroblast activation protein, alpha; FAP 14 2 9 NM_033238.2 promyelocytic leukemia; PML 14 2 10 NM_004104.4 fatty acid synthase; FASN 14 2 11 NM_002960.1 S100 calcium binding protein A3; S100A3 14 2 12 BC053585.1 colony stimulating factor 3 receptor (granulocyte); CSF3R 14 3 1 NM_170662.3 Cas-Br-M (murine) ecotropic retroviral transforming sequence b; CBLB 14 3 2 NM_003732.2 eukaryotic translation initiation factor 4E binding protein 3; EIF4EBP3 14 3 3 NM_003269.2 nuclear receptor subfamily 2, group E, member 1; NR2E1 14 3 4 NM_005596.2 nuclear factor I/B; NFIB 14 3 5 NM_006153.3 NCK adaptor protein 1; NCK1 14 3 6 NM_000112.2 solute carrier family 26 (sulfate transporter), member 2; SLC26A2 14 3 7 AY585189.1 RAB23, member RAS oncogene family; RAB23 14 3 8 BC108650.1 nibrin; NBN 14 3 9 NM_005414.2 SKI-like; SKIL 14 3 10 NM_002104.2 granzyme K (granzyme 3; tryptase II); GZMK 14 3 11 NM_006502.1 polymerase (DNA directed), eta; POLH 14 3 12 NM_022564.2 matrix metallopeptidase 16 (membrane-inserted); MMP16 14 4 1 NM_014049.3 acyl-Coenzyme A dehydrogenase family, member 9; ACAD9 14 4 2 NM_002302.2 leukocyte cell-derived chemotaxin 2; LECT2 14 4 3 BT019655.1 mitogen-activated protein kinase kinase kinase 7; MAP3K7 14 4 4 U18914.1 tumor protein D52; TPD52 14 4 5 NM_000648.1 chemokine (C-C motif) receptor 2; CCR2 14 4 6 NM_000588.3 interleukin 3 (colony-stimulating factor, multiple); IL3 14 4 7 NM_005588.1 meprin A, alpha (PABA peptide hydrolase); MEP1A 14 4 8 NM_004219.2 pituitary tumor-transforming 1; PTTG1 14 4 9 BC007401.2 cell division cycle 25A; CDC25A 14 4 10 NM_003059.2 solute carrier family 22 (organic cation transporter), member 4; SLC22A4 14 4 11 NM_006061.1 cysteine-rich secretory protein 3; CRISP3 14 4 12 NM_003235.4 thyroglobulin; TG 14 5 1 AY656701.1 brain-derived neurotrophic factor; BDNF 14 5 2 X64838.1 restin (Reed-Steinberg cell-expressed intermediate filament-associated protein); RSN 14 5 3 NM_145113.1 MYC associated factor X; MAX 14 5 4 NM_013275.4 ankyrin repeat domain 11; ANKRD11 14 5 5 NM_000728.3 calcitonin-related polypeptide, beta; CALCB 14 5 6 BC006506.2 amplified in osteosarcoma; OS9 14 5 7 NM_014360.2 NK2 transcription factor related, locus 8 (Drosophila); NKX2-8 14 5 8 NM_004413.1 dipeptidase 1 (renal); DPEP1 14 5 9 AP000593.4 Homo sapiens genomic DNA, chromosome 11q, clone:CMB9-4J8, complete sequence; ; 14 5 10 BC005961.1 parathyroid hormone-like hormone; PTHLH 14 5 11 CR614497.1 full-length cDNA clone CS0DD002YA12 of Neuroblastoma Cot 50-normalized of Homo sapiens (human);; 14 5 12 NM_005147.3 DnaJ (Hsp40) homolog, subfamily A, member 3; DNAJA3 14 6 1 NM_002727.2 proteoglycan 1, secretory granule; PRG1 14 6 2 BC019925.1 thymine-DNA glycosylase; TDG 14 6 3 NM_001911.2 cathepsin G; CTSG 14 6 4 NM_003745.1 suppressor of cytokine signaling 1; SOCS1 14 6 5 BC063019.1 solute carrier family 29 (nucleoside transporters), member 3; SLC29A3 14 6 6 NM_000017.1 acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain; ACADS 14 6 7 BC019343.1 TERF1 (TRF1)-interacting nuclear factor 2; TINF2 14 6 8 BC013207.1 G protein-coupled receptor 56; GPR56 14 6 9 NM_002779.3 pleckstrin and Sec7 domain containing; PSD 14 6 10 NM_001175.4 Rho GDP dissociation inhibitor (GDI) beta; ARHGDIB 14 6 11 NM_002376.4 MAP/microtubule affinity-regulating kinase 3; MARK3 14 6 12 NM_002811.3 proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 (Mov34 homolog); PSMD7 14 7 1 NM_001071.1 thymidylate synthetase; TYMS 14 7 2 BC007777.2 zinc finger protein 42 (myeloid-specific retinoic acid-responsive); ZNF42 14 7 3 NM_000026.1 adenylosuccinate lyase; ADSL 14 7 4 NM_000233.1 luteinizing hormone/choriogonadotropin receptor; LHCGR 14 7 5 BC096222.1 synovial sarcoma translocation, chromosome 18; SS18 14 7 6 BC017285.2 coatomer protein complex, subunit epsilon; COPE 14 7 7 BC073754.1 activating transcription factor 4 (tax-responsive enhancer element B67); ATF4 14 7 8 AB209634.1 AF4/FMR2 family, member 3; AFF3 14 7 9 NM_012397.2 serpin peptidase inhibitor, clade B (ovalbumin), member 13; SERPINB13 14 7 10 NM_000435.1 Notch homolog 3 (Drosophila); NOTCH3 14 7 11 K01401.1 platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog); PDGFB 14 7 12 NM_003183.4 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme); ADAM17 14 8 1 NM_002035.1 follicular lymphoma variant translocation 1; FVT1 14 8 2 NM_005860.2 follistatin-like 3 (secreted glycoprotein); FSTL3 14 8 3 BC067751.1 v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian); MAFF 14 8 4 NM_004490.2 growth factor receptor-bound protein 14; GRB14 14 8 5 NM_000633.2 B-cell CLL/lymphoma 2; BCL2 14 8 6 NM_001928.2 D component of complement (adipsin); DF 14 8 7 NM_000395.1 colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage); CSF2RB 14 8 8 BC068441.1 interleukin 1 receptor antagonist; IL1RN 14 8 9 NM_003927.3 methyl-CpG binding domain protein 2; MBD2 14 8 10 BC000114.1 megakaryocyte-associated tyrosine kinase; MATK 14 8 11 NM_000362.4 TIMP metallopeptidase inhibitor 3 (Sorsby fundus dystrophy, pseudoinflammatory); TIMP3 14 8 12 NM_003385.4 visinin-like 1; VSNL1 14 9 1 NM_002451.3 methylthioadenosine phosphorylase; MTAP 14 9 2 obsaracontrol#015 control oligonucleotide 14 9 3 X57019.1 AXL receptor tyrosine kinase; AXL 14 9 4 NM_006625.3 FUS interacting protein (serine/arginine-rich) 1; FUSIP1 14 9 5 AF086912.1 osteoglycin (osteoinductive factor, mimecan); OGN 14 9 6 BC007946.2 interleukin 21 receptor; IL21R 14 9 7 AY438030.1 BRCA1/BRCA2-containing complex, subunit 3; BRCC3 14 9 8 BC004257.1 ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease); RET 14 9 9 NM_002957.3 retinoid X receptor, alpha; RXRA 14 9 10 NM_004530.2 matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase); MMP2 14 9 11 NM_017489.1 telomeric repeat binding factor (NIMA-interacting) 1; TERF1 14 9 12 NM_002346.1 lymphocyte antigen 6 complex, locus E; LY6E 14 10 1 X63432 beta-actin, replicated spot 14 10 2 NM_001257.3 cadherin 13, H-cadherin (heart); CDH13 14 10 3 NM_002367.2 melanoma antigen family B, 4; MAGEB4 14 10 4 NM_153759.2 DNA (cytosine-5-)-methyltransferase 3 alpha; DNMT3A 14 10 5 NM_019851.1 fibroblast growth factor 20; FGF20 14 10 6 NM_003561.1 phospholipase A2, group X; PLA2G10 14 10 7 NM_012337.2 coiled-coil domain containing 19; CCDC19 14 10 8 NM_005862.2 stromal antigen 1; STAG1 14 10 9 NM_006197.2 pericentriolar material 1; PCM1 14 10 10 NM_002499.1 neogenin homolog 1 (chicken); NEO1 14 10 11 BC103863.1 synovial sarcoma, X breakpoint 2; SSX2 14 10 12 X01677 glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA, complete cds; glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12), replicated spot 15 1 1 M26880 ubiquitin_2 15 1 2 NM_002005.2 feline sarcoma oncogene; FES 15 1 3 NM_016190.1 cornulin; CRNN 15 1 4 U58143.1 caspase 8, apoptosis-related cysteine peptidase; CASP8 15 1 5 NM_001312.2 cysteine-rich protein 2; CRIP2 15 1 6 BC100913.1 CD8 antigen, beta polypeptide 1 (p37); CD8B1 15 1 7 NM_022873.2 interferon, alpha-inducible protein (clone IFI-6-16); G1P3 15 1 8 NM_012214.2 mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A; MGAT4A 15 1 9 D37933.1 Human mRNA for SYNTAXIN1B, complete cds; ; 15 1 10 BC008727.2 retinoic acid receptor, alpha; RARA 15 1 11 NM_005764.3 PDZK1 interacting protein 1; PDZK1IP1 15 1 12 BT019918.1 proopiomelanocortin (adrenocorticotropin/ beta-lipotropin/ alpha-melanocyte stimulating hormone/ beta-melanocyte stimulating hormone/ beta-endorphin); POMC 15 2 1 U04845.1 collagen, type IV, alpha 6; COL4A6 15 2 2 NM_000397.2 cytochrome b-245, beta polypeptide (chronic granulomatous disease); CYBB 15 2 3 NM_003579.2 RAD54-like (S. cerevisiae); RAD54L 15 2 4 NM_000379.3 xanthine dehydrogenase; XDH 15 2 5 NM_000530.4 myelin protein zero (Charcot-Marie-Tooth neuropathy 1B); MPZ 15 2 6 NM_002607.4 platelet-derived growth factor alpha polypeptide; PDGFA 15 2 7 NM_000779.2 cytochrome P450, family 4, subfamily B, polypeptide 1; CYP4B1 15 2 8 NM_003387.3 Wiskott-Aldrich syndrome protein interacting protein; WASPIP 15 2 9 M11955.1 T cell receptor beta variable 20-1; TRBV20-1 15 2 10 NM_001565.1 chemokine (C-X-C motif) ligand 10; CXCL10 15 2 11 NM_012128.2 chloride channel, calcium activated, family member 4; CLCA4 15 2 12 S51768.1 regenerating islet-derived 3 alpha; REG3A 15 3 1 NM_000729.3 cholecystokinin; CCK 15 3 2 NM_003118.2 secreted protein, acidic, cysteine-rich (osteonectin); SPARC 15 3 3 BC014564.2 mesoderm specific transcript homolog (mouse); MEST 15 3 4 CR749354.1 Rap guanine nucleotide exchange factor (GEF) 1; RAPGEF1 15 3 5 NM_000666.1 aminoacylase 1; ACY1 15 3 6 AY358984.1 mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B; MGAT4B 15 3 7 BC028689.2 tripartite motif-containing 24; TRIM24 15 3 8 NM_004959.3 nuclear receptor subfamily 5, group A, member 1; NR5A1 15 3 9 NG_003186.1 transcription elongation factor A (SII), 1 pseudogene; LOC399511 15 3 10 NM_002372.2 mannosidase, alpha, class 2A, member 1; MAN2A1 15 3 11 BC000013.2 insulin-like growth factor binding protein 3; IGFBP3 15 3 12 BC012612.1 cathepsin L; CTSL 15 4 1 obsaracontrol#014 control oligonucleotide 15 4 2 BC040457.1 calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha; CAMK2A 15 4 3 NM_000603.3 nitric oxide synthase 3 (endothelial cell); NOS3 15 4 4 NM_000550.1 tyrosinase-related protein 1; TYRP1 15 4 5 BC023599.2 TRK-fused gene; TFG 15 4 6 BT020021.1 excision repair cross-complementing rodent repair deficiency, complementation group 8; ERCC8 15 4 7 AY380060.1 KRIT1, ankyrin repeat containing; KRIT1 15 4 8 NM_002173.1 interferon, alpha 16; IFNA16 15 4 9 NM_000882.2 interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35); IL12A 15 4 10 NM_000414.1 hydroxysteroid (17-beta) dehydrogenase 4; HSD17B4 15 4 11 NM_004126.3 guanine nucleotide binding protein (G protein), gamma 11; GNG11 15 4 12 NM_002176.2 interferon, beta 1, fibroblast; IFNB1 15 5 1 BC008799.2 cortactin; CTTN 15 5 2 NM_003348.3 ubiquitin-conjugating enzyme E2N (UBC13 homolog, yeast); UBE2N 15 5 3 NM_004995.2 matrix metallopeptidase 14 (membrane-inserted); MMP14 15 5 4 BC085615.1 breast cancer 1, early onset; BRCA1 15 5 5 BC040484.1 MAP-kinase activating death domain; MADD 15 5 6 NM_016057.1 coatomer protein complex, subunit zeta 1; COPZ1 15 5 7 NM_000270.1 nucleoside phosphorylase; NP 15 5 8 NM_000151.1 glucose-6-phosphatase, catalytic (glycogen storage disease type I, von Gierke disease); G6PC 15 5 9 NM_001293.1 chloride channel, nucleotide-sensitive, 1A; CLNS1A 15 5 10 NM_000924.2 phosphodiesterase 1B, calmodulin-dependent; PDE1B 15 5 11 NM_007110.3 telomerase-associated protein 1; TEP1 15 5 12 AF498925.1 growth factor receptor-bound protein 2; GRB2 15 6 1 NM_176795.2 v-Ha-ras Harvey rat sarcoma viral oncogene homolog; HRAS 15 6 2 NM_003482.1 myeloid/lymphoid or mixed-lineage leukemia 2; MLL2 15 6 3 Y14330.1 jagged 2; JAG2 15 6 4 NM_001545.1 immature colon carcinoma transcript 1; ICT1 15 6 5 NM_053056.2 cyclin D1; CCND1 15 6 6 NM_019034.2 ras homolog gene family, member F (in filopodia); RHOF 15 6 7 NM_002877.4 RAD51-like 1 (S. cerevisiae); RAD51L1 15 6 8 NM_001140.3 arachidonate 15-lipoxygenase; ALOX15 15 6 9 AF092922.1 retinoic acid receptor responder (tazarotene induced) 3; RARRES3 15 6 10 NM_005276.2 glycerol-3-phosphate dehydrogenase 1 (soluble); GPD1 15 6 11 NM_002632.4 placental growth factor, vascular endothelial growth factor-related protein; PGF 15 6 12 BC018056.1 septin 4; SEPT4 15 7 1 NM_006202.1 phosphodiesterase 4A, cAMP-specific (phosphodiesterase E2 dunce homolog, Drosophila); PDE4A 15 7 2 NM_002827.2 protein tyrosine phosphatase, non-receptor type 1; PTPN1 15 7 3 AK092463.1 melanoma antigen family D, 2; MAGED2 15 7 4 NM_004656.2 BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase); BAP1 15 7 5 NM_001022.3 ribosomal protein S19; RPS19 15 7 6 NM_006097.3 myosin, light polypeptide 9, regulatory; MYL9 15 7 7 NM_006521.3 transcription factor binding to IGHM enhancer 3; TFE3 15 7 8 NM_021105.1 phospholipid scramblase 1; PLSCR1 15 7 9 BC050450.1 Lutheran blood group (Auberger b antigen included); LU 15 7 10 AL034418.5 Human DNA sequence from clone RP5-1049G16 on chromosome 20q12-13.2 Contains the 3' end of the NCOA3 gene for nuclear receptor coactivator 3, an RPS3A (ribosomal protein S3A) pseudogene and the 3' end of the gene for a novel protein similar to glucosamine-6-sulfatases (SULF2) (sulfatase 2, H-SULF2, KIAA1247), complete sequence 15 7 11 NM_007003.2 P antigen family, member 4 (prostate associated); PAGE4 15 7 12 NM_001068.2 topoisomerase (DNA) II beta 180kDa; TOP2B 15 8 1 NM_005178.2 B-cell CLL/lymphoma 3; BCL3 15 8 2 NM_014071.2 nuclear receptor coactivator 6; NCOA6 15 8 3 NM_003639.2 inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; IKBKG 15 8 4 NM_003875.2 guanine monphosphate synthetase; GMPS 15 8 5 NM_000041.2 apolipoprotein E; APOE 15 8 6 BC107886.1 RNA-binding region (RNP1, RRM) containing 2; RNPC2 15 8 7 AB209316.1 TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa; TAF1 15 8 8 BC022524.1 fibroblast growth factor 12; FGF12 15 8 9 NM_003430.1 zinc finger protein 91 (HPF7, HTF10); ZNF91 15 8 10 NM_012325.1 microtubule-associated protein, RP/EB family, member 1; MAPRE1 15 8 11 NM_018486.1 histone deacetylase 8; HDAC8 15 8 12 NM_006217.3 serpin peptidase inhibitor, clade I (pancpin), member 2; SERPINI2 15 9 1 BC013876.2 optineurin; OPTN 15 9 2 BC006535.2 growth factor receptor-bound protein 7; GRB7 15 9 3 NM_020991.3 chorionic somatomammotropin hormone 2; CSH2 15 9 4 NM_000769.1 cytochrome P450, family 2, subfamily C, polypeptide 19; CYP2C19 15 9 5 NR_002726.1 heterogeneous nuclear ribonucleoprotein A3 pseudogene 1; HNRPA3P1 15 9 6 NM_003255.4 TIMP metallopeptidase inhibitor 2; TIMP2 15 9 7 NM_000553.2 Werner syndrome; WRN 15 9 8 NM_021111.1 reversion-inducing-cysteine-rich protein with kazal motifs; RECK 15 9 9 NM_005410.2 selenoprotein P, plasma, 1; SEPP1 15 9 10 NM_004774.2 PPAR binding protein; PPARBP 15 9 11 NM_001005.3 ribosomal protein S3; RPS3 15 9 12 NM_000990.3 ribosomal protein L27a; RPL27A 15 10 1 L25899 Ribosomal protein L10 15 10 2 NM_001033053.1 NACHT, leucine rich repeat and PYD (pyrin domain) containing 1; NALP1 15 10 3 NM_004832.1 glutathione S-transferase omega 1; GSTO1 15 10 4 NM_017533.1 myosin, heavy polypeptide 4, skeletal muscle; MYH4 15 10 5 AF528099.1 transforming, acidic coiled-coil containing protein 2; TACC2 15 10 6 NM_006273.2 chemokine (C-C motif) ligand 7; CCL7 15 10 7 AC020907.6 Homo sapiens chromosome 19 clone CTD-2527I21, complete sequence;; 15 10 8 BC009545.1 fasciculation and elongation protein zeta 1 (zygin I); FEZ1 15 10 9 NM_004508.2 isopentenyl-diphosphate delta isomerase 1; IDI1 15 10 10 NM_012448.3 signal transducer and activator of transcription 5B; STAT5B 15 10 11 NM_000315.2 parathyroid hormone; PTH 15 10 12 L25899 Ribosomal protein L10 16 1 1 X01677 glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA, complete cds; glyceraldehyde-3-phosphate dehydrogenase (EC 1.2.1.12), replicated spot 16 1 2 NM_001214.3 chromosome 16 open reading frame 3; C16orf3 16 1 3 NM_005814.1 glycoprotein A33 (transmembrane); GPA33 16 1 4 NM_002664.1 pleckstrin; PLEK 16 1 5 NM_005292.2 G protein-coupled receptor 18; GPR18 16 1 6 NM_018402.1 interleukin 26; IL26 16 1 7 NM_002585.1 pre-B-cell leukemia transcription factor 1; PBX1 16 1 8 NM_000599.2 insulin-like growth factor binding protein 5; IGFBP5 16 1 9 NM_006497.2 hypermethylated in cancer 1; HIC1 16 1 10 NM_000476.1 adenylate kinase 1; AK1 16 1 11 NM_001100.3 actin, alpha 1, skeletal muscle; ACTA1 16 1 12 X63432 beta-actin, replicated spot 16 2 1 BC032539.1 mitogen-activated protein kinase 9; MAPK9 16 2 2 NM_001540.2 heat shock 27kDa protein 1; HSPB1 16 2 3 NM_006341.2 MAD2 mitotic arrest deficient-like 2 (yeast); MAD2L2 16 2 4 Y00664.1 v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian); MYCN 16 2 5 NM_000958.2 prostaglandin E receptor 4 (subtype EP4); PTGER4 16 2 6 NM_000879.2 interleukin 5 (colony-stimulating factor, eosinophil); IL5 16 2 7 NM_003902.3 far upstream element (FUSE) binding protein 1; FUBP1 16 2 8 BC041868.1 vacuolar protein sorting 54 (yeast); VPS54 16 2 9 NM_003335.2 ubiquitin-activating enzyme E1-like; UBE1L 16 2 10 BC016308.1 chemokine (C-X-C motif) ligand 3; CXCL3 16 2 11 NM_000120.2 epoxide hydrolase 1, microsomal (xenobiotic); EPHX1 16 2 12 NM_001927.3 desmin; DES 16 3 1 NM_003998.2 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105); NFKB1 16 3 2 BC001358.2 mutS homolog 5 (E. coli); MSH5 16 3 3 NM_001753.3 caveolin 1, caveolae protein, 22kDa; CAV1 16 3 4 NM_000368.3 tuberous sclerosis 1; TSC1 16 3 5 NM_016619.1 placenta-specific 8; PLAC8 16 3 6 BC002377.2 PTK7 protein tyrosine kinase 7; PTK7 16 3 7 NM_002649.2 phosphoinositide-3-kinase, catalytic, gamma polypeptide; PIK3CG 16 3 8 AF095737.2 sarcosine dehydrogenase; SARDH 16 3 9 NM_000027.2 aspartylglucosaminidase; AGA 16 3 10 NM_004761.2 ral guanine nucleotide dissociation stimulator-like 2; RGL2 16 3 11 AC002467.1 Homo sapiens BAC clone CTA-364P16 from 7, complete sequence; ; 16 3 12 BC003110.1 interleukin 11 receptor, alpha; IL11RA 16 4 1 NM_017830.1 OCIA domain containing 1; OCIAD1 16 4 2 obsaracontrol#015 control oligonucleotide 16 4 3 NM_004403.1 deafness, autosomal dominant 5; DFNA5 16 4 4 NM_004878.3 prostaglandin E synthase; PTGES 16 4 5 NM_006419.1 chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant); CXCL13 16 4 6 BC103835.1 PR domain containing 1, with ZNF domain; PRDM1 16 4 7 NM_019102.2 homeo box A5; HOXA5 16 4 8 NM_013443.3 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6; ST6GALNAC6 16 4 9 NM_003925.1 methyl-CpG binding domain protein 4; MBD4 16 4 10 NM_006834.2 RAB32, member RAS oncogene family; RAB32 16 4 11 AC141846.3 Homo sapiens chromosome 16 clone CTB-55P19, complete sequence; ; 16 4 12 NM_003165.1 syntaxin binding protein 1; STXBP1 16 5 1 NM_007103.2 NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa; NDUFV1 16 5 2 NM_006768.2 BRCA1 associated protein; BRAP 16 5 3 NM_002420.4 transient receptor potential cation channel, subfamily M, member 1; TRPM1 16 5 4 BC093042.1 protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1); PRKAR1A 16 5 5 BT019698.1 RAB6A, member RAS oncogene family; RAB6A 16 5 6 NM_016162.2 inhibitor of growth family, member 4; ING4 16 5 7 NM_001482.1 glycine amidinotransferase (L-arginine:glycine amidinotransferase); GATM 16 5 8 BT019484.1 RAB5C, member RAS oncogene family; RAB5C 16 5 9 NM_003146.2 structure specific recognition protein 1; SSRP1 16 5 10 NM_001273.2 chromodomain helicase DNA binding protein 4; CHD4 16 5 11 NM_016396.1 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2; CTDSPL2 16 5 12 NM_006688.3 complement component 1, q subcomponent-like 1; C1QL1 16 6 1 NM_003627.4 solute carrier family 43, member 1; SLC43A1 16 6 2 NM_001242.3 tumor necrosis factor receptor superfamily, member 7; TNFRSF7 16 6 3 NM_000781.1 cytochrome P450, family 11, subfamily A, polypeptide 1; CYP11A1 16 6 4 AF047863.1 microtubule-associated protein tau; MAPT 16 6 5 NM_001418.1 eukaryotic translation initiation factor 4 gamma, 2; EIF4G2 16 6 6 NM_001769.2 CD9 antigen (p24); CD9 16 6 7 BC002479.2 cathepsin H; CTSH 16 6 8 BT006844.1 granulin; GRN 16 6 9 NM_001562.2 interleukin 18 (interferon-gamma-inducing factor); IL18 16 6 10 NM_005810.3 killer cell lectin-like receptor subfamily G, member